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CHAPTER I  
 
PROTEIN-PROTEIN INTERACTIONS OF INWARD RECTIFYING POTASSIUM 
CHANNELS 
 
 
Introduction 
Inward rectifying potassium (Kir) channels are one of the largest groups of ion channel 
families found in mammalian cells. This group of membrane proteins plays various roles in 
physiology from potassium channel transport in the kidney to controlling excitability within 
neurons. So essential is the function of these membrane proteins, that mutations within the family 
are linked to various human diseases (Abraham, Jahangir et al. 1999, Hejtmancik, Jiao et al. 2008). 
Few drugs directly target these Kirs, however these  channels often act in concert with other 
proteins in the cell such as G-protein coupled receptors (GPCRs). These interacting proteins can 
modulate channel function to play various roles in physiology, with some being indeed druggable. 
Here we explore these ion channels and protein-protein interactions that regulate their function in 
physiology. 
 
Molecular structure and function of potassium inward rectifiers 
 Kirs are a subgroup of potassium channels comprised of two transmembrane domains 
(Fig 1.1A). These transmembrane domains are linked by an extracellular region which form the 
pore domain, with both the amino and carboxyl terminal of the channel intracellularly located.  
The Kir family is composed of 16 channels from three different subgroups; potassium transporters 
(Kir1.x, Kir7.1, Kir4.x, Kir5.1), classical Kir channels (Kir2.x), G-protein gated K+ channels 
(GIRK, Kir3.x) and ATP-sensitive K+ channels (Kir6.x) (Hibino, Inanobe et al. 2010) (Fig 1.1B). 
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Individual Kir subunits assemble as a tetramer to form a functional ion channel (Fig 1.1A). 
Channels typically form homo-tetramers, except Kir5.1 which assembles with Kir4.1 in order to 
form a functional channel (Konstas, Korbmacher et al. 2003, Hibino, Fujita et al. 2004). Kir2.x 
exist as homo-tetramers but can also form hetero-tetramers with other family subunits (Gernot, 
Peter et al. 2002, Lior, Lisa et al. 2011). 
 
Pore domain and selectivity filter 
The pore domain of the channel, referred to as the H5 region, is comprised of the ion 
selectivity filter with the sequence T-X-G-Y-G, which is shared with other potassium selective ion 
channels (Doyle, Cabral et al. 1998, Shealy, Murphy et al. 2003). In addition to the selectivity 
filter, Kir channels also share an arginine residue nearby G-Y-G-X-R-X, the absence of which 
leads to smaller currents as seen in Kir7.1, that has a methionine present in its pore (G-Y-G-X-M-
X) (Doring, Derst et al. 1998). Replacement of methionine 125 in Kir7.1 with arginine allows 
larger currents from these channels. This pore domain is also known to be susceptible to blockade 
by intracellular cations such as Mg2+ and polyamines (Kurata, Cheng et al. 2011).   
 
Post-translational modifications 
Inward rectifiers possess classical sites for post translation modification such as 
phosphorylation and glycosylation. Protein kinase A (PKA) and protein kinase C (PKC) can 
modulate the activity of these channels by phosphorylation of serine or tyrosine residues located 
in the C-terminal tail. Phosphorylation can have various effects on channel function. For example, 
phosphorylation of Kir6.2 by PKA enhances channel activity (Béguin, Nagashima et al. 1999). 
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Additionally, phosphorylation can also affect protein trafficking; for example,  Kir1.1 requires 
PKC phosphorylation for surface expression (Lin, Sterling et al. 2002).  
Figure 1.1 Structure and function of inwardly rectifying potassium channels 
A. Schematic of an individual Kir channel subunit with two transmembrane domains TM1 and 
TM2. Channel subunits assemble as functional tetramers forming a single pore in the center. B. 
The Kir family is composed of 16 different subtypes classified into four groups. The phylogenetic 
tree was generated using online phylogeny software (Dereeper, Guignon et al. 2008). C. 
Representative current-voltage (I/V) curve of a Kir channel. At negative potentials potassium 
flows into the cell generating an inward current (1). When the Nernst (EK) potential for potassium 
is reached, Kirs allow the outflow of potassium ions as an outward current (2). As the membrane 
becomes more positive to EK the pore becomes blocked by cations or polyamines in a process 
known as rectification.  
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Kir channels can also undergo glycosylation which plays a role in the function of some 
channels. Kirs exhibit N-linked glycosylation, with no reports of O-linked glycosylation in 
literature. Kir1.1 and Kir7.1 require glycosylation for effective function, as reduced open channel 
probabilities are observed in glycosylation resistant mutants (Schwalbe, Wang et al. 1995, 
Carrington, Hernandez et al. 2018). While other channels are observed to be glycosylated such as 
Kir4.1, roles for glycosylation remain unclear in these channels. Putative glycosylation sites are 
located in extracellular loops of the channel which may suggest a functional consequence on 
channel activity.  
  
Binding domains 
Inward rectifiers can be regulated by the binding of lipids or other proteins directly to their 
subunits. Kir channels have a phosphatidylinositol 4,5-bisphosphate (PIP2) binding site which is 
essential for channel gating (Stansfeld, Hopkinson et al. 2009, Hansen, Tao et al. 2011). This site 
is located between the transmembrane domain and the interface of the C-terminal domain (Hansen, 
Tao et al. 2011). The binding of PIP2 aids channel gating, and its depletion leads to “channel 
rundown” with a decline in activity. This activity can be rescued if PIP2 is replenished within the 
cell.  
 These channels also have binding sites for adenosine triphosphate (ATP), with KATP 
channels widely shown to be most sensitive (Craig, Ashcroft et al. 2008).  KATP channels are 
comprised of Kir6.x and the unrelated sulfonylurea receptor subunits (SUR) (Martin, Yoshioka et 
al. 2017). These complexes are inhibited by ATP binding to cytoplasmic regions within Kir6.x 
(Antcliff, Haider et al. 2005, Craig, Ashcroft et al. 2008), with ATP binding to SUR as well. The 
protein-protein interaction of SUR1 and Kir6.x is discussed in more detail later in this chapter. 
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Channel function 
 Kir channels selectively carry potassium ions across the membrane of the cell with 
changes in membrane potential. These channels respond to changes in voltage across the cell, but 
they lack the positively charged S4 transmembrane voltage sensing domain found in classical 
voltage gated ion channels. The movement of ions into the cell is called inward current, and out of 
the cell as outward current (Fig 1.1C). These channels have larger inward currents due to their 
rectification properties. Simply, at membrane potentials negative to the equilibrium potential of 
potassium (Nernst potential or EK), Kir channels allow the flow of potassium ions into the cell (Fig 
1.1C-1). As the membrane potential becomes more positive to EK, potassium ions flow out of the 
channel generating outward currents (Fig 1.1C-2).  These outward currents are limited as 
intracellular cations (Mg2+) and polyamines block the outward flow of potassium as the membrane 
potential becomes more positive (Fig 1.1C-3). The blockade of additional outward currents at 
positive potentials is termed “inward rectification” (Lu 2004). 
  
Regulation of inward rectifiers by protein-protein interactions 
Kir channels can be regulated by direct protein-protein interactions which control pore 
function. Current known interactors are various receptor subunits, G-proteins and 
anchoring/scaffolding proteins such as PSD95 (Fig 1.2). These proteins will be explored in more 
detail in this section. 
 
Receptor subunits 
The sulphonylurea receptor (SUR) is an ATP-binding cassette (ABC) transporter that is 
part of a large group of membrane proteins. These proteins use ATP hydrolysis to generate energy 
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to transport substances across the cell membrane (Aittoniemi, Fotinou et al. 2009). Whereas ABC 
transporters function as independent units to transport molecules across the membrane, the 
sulphonyl urea class of receptors are coupled to the Kir6.x ion channel to form the KATP channel. 
SURs assemble 1:1 with Kir6.x subunits to form an octameric complex. While there are two types 
of SUR- SUR1 and SUR2, SUR1 assembles with Kir6.2 to form the KATP channel in beta cells of 
the pancreas (Li, Wu et al. 2017). SUR1 expression is also required for Kir6.2 surface expression, 
due to an endoplasmic reticulum (ER) retention signal on the channel which requires SUR for 
release and transport to the membrane (Zerangue, Schwappach et al. 1999).  SURs are composed 
of 3 transmembrane domains (TMD0-TMD2) which have 4-6 transmembrane helixes. The 
intracellular loop of the receptor between TMD1 and TMD2 and the C terminal tail form two 
nucleotide binding domains (NBDs) that sense changes in intracellular nucleotides. SUR is directly 
coupled to Kir6.2 by the intercellular loop between TMD0 and TMD1 interacting with 7 residues 
on the N terminal of Kir6.2 (Li, Wu et al. 2017). Interestingly, it was recently shown that the 
binding of PIP2 to Kir6.2 can uncouple the interaction of SUR and the channel (Li, Wu et al. 
2017). The PIP2 binding site partially overlaps with the SUR1/Kir6.2 interacting region, which 
was revealed by Cryo-EM.  
Within beta cells when glucose levels are low, MgADP binds to the NBD of SUR causing 
Kir6.2 to open which hyperpolarizes the cell and reduces insulin release (Aittoniemi, Fotinou et 
al. 2009). When glucose levels are high causing increased ATP in the cell, ATP binds directly to 
Kir6.2 leading to channel closure, membrane depolarization and insulin release. The sensitivity of 
SUR1 to glucose levels has allowed this system to be targeted in the treatment of diabetes. 
Glibenclamide is a widely used diabetes drug that binds to and inhibits SUR1 by inducing an 
inactive confirmation (Proks, Reimann et al. 2002). SUR is thereby unable to respond to changes 
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in MgADP leaving Kir6.2 in the closed state. This allows the cell to depolarize promoting insulin 
release.  KATP channels also exist in muscles and cardiac cells (Gribble, Tucker et al. 1998). Thus, 
Kir6.2 channels can be regulated directly by a receptor to play a key role in cellular function.  
The cystic fibrosis transmembrane conductance regulator (CFTR) is another ABC 
transporter shown to form weak KATP channels with a splice variant of Kir1.1 in the Kidney 
(Ruknudin, Schulze et al. 1998). Kir1.1 channels are involved in potassium transport and different 
isoforms are expressed along the nephron (Kir1.1a-c)(Welling and Ho 2009). Each isoform has a 
different physiological function. CFTR assembles with Kir1.1b and bestows weak sulphonyl urea 
and ATP sensitivity to the channel. Unlike the SUR/Kir6.2 KATP channel, the interaction of CFTR 
and Kir1.1 appears to be dependent on Na/H exchange regulatory factors (NHERF1/2) which serve 
as a scaffolds to support CFTR/Kir1.1 coupling (Yoo, Flagg et al. 2004). The mechanism of CFTR 
inhibition of Kir1.1 is thought to be indirect and not clearly understood, but PKA mediated 
phosphorylation of the channel uncouples the interaction and relieves ATP-dependent inhibition. 
Unlike Sur1 and Kir6.2, Kir1.1 does not require CFTR for surface expression.  
 
GPCRs 
 G-protein coupled receptors (GPCRs) are one of the largest druggable classes of proteins 
in therapeutics. These seven transmembrane domain receptors regulate a wide range of functions 
in all tissues. GPCRs transduce signals within a cell via effectors called G-proteins which activate 
various signaling pathways. In a broad sense, GPCRs can activate Galpha (G)  subunits which 
can be stimulatory (Gs) proteins or inhibitory (Gi) proteins and other classes such as Gq. G 
proteins exist in a trimeric complex with Gbeta (G) and Ggamma (G) proteins. Activation of the 
receptor leads to activation of the G subunit causing the release of the G complex to mediate 
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their effects (Smrcka 2008). Kirs are typically regulated by GPCRs via G complexes (Hommers, 
Lohse et al. 2003). As such, G -protein inwardly rectifying potassium channels (GIRKs) are 
activated by G proteins after receptor activation. GIRK channels are coupled through Gi linked 
GPCRs such as M2 muscarinic receptors in the heart (Wang, Liang et al. 2013). These GPCRs can 
directly associate in complex with Kir channels even though they couple indirectly (Lavine, Ethier 
et al. 2002). To date only the melanocortin-4 receptor (MC4R) has been reported to signal through 
Kir7.1 channel independently of G proteins (Ghamari-Langroudi, Digby et al. 2015, Anderson, 
Çakir et al. 2016) (see appendix). The exact mechanism of interaction remains unknown. Outside 
of this, studies have been published with engineered GPCR-Kir subunits to create ligand-gated Kir 
channels (Moreau, Revilloud et al. 2017). In these proteins, the GPCRs mechanically transduce 
their signal through the N-terminal of the Kir channel to cause channel opening or closing. The 
length of the N terminal region of the channel and the GPCR may be altered to  activate or inhibit 
the system. This allows channel activity to be used as an artificial read out of GPCR activity and 
may suggest a possible mechanism for the MC4R-Kir7.1 interaction. 
 GPCRs can also regulate the trafficking of Kir channels to control function. The calcium 
sensing receptor (CaR) is a GPCR expressed in the kidney that regulates salt and water transport. 
CaR was found to interact with Kir4.1 and Kir4.2 and regulate channel activity by reducing its 
surface expression (Cha, Huang et al. 2011). The reduction in Kir4.1 surface expression was 
proportional to the activity of the GPCR, in that non-functional GPCRs failed to have an effect on 
the channel. This effect was mediated by G protein Gq and caveolin-1 dependent internalization 
pathways. The mechanism by which Gq leads to caveolin-1 mediated internalization, however, 
remains unclear. GIRK channel surface expression can also be regulated by the GPCRs to which 
they couple and form complexes. GPCR signaling is generally switched off by receptor 
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phosphorylation and the recruitment of beta arrestin proteins. Beta-arrestins lead to the recruitment 
of clathrin, a vesicle membrane coat protein that mediates endocytosis. GIRK channels have been 
observed to co-internalize with the delta opioid GPCR following receptor desensitization (Nagi, 
Charfi et al. 2015). GPCRs can thus regulate GIRK channels through G protein mediated 
activation, and removal of channels from the membrane.  
 
G-proteins 
GIRK channels are the Kir3.x subfamily whose activity is coupled directly to G-protein 
signaling. D2 and M2 GPCRs are known to couple to GIRK channels in the brain and in the case 
of M2, in other tissues like the heart (Harvey and Belevych 2003, Huang, Griffin et al. 2013). 
GPCRs that couple to GIRKs are predominantly Gi coupled receptors. As described previously, 
GIRK channels are activated by G proteins which are released from the complex after GPCR 
activation. The exact mechanism is unknown, but it is thought that residues in the N and C terminal 
domains of the channel interact with the G complex to mediate channel activation (He, Yan et 
al. 2002).  
Interestingly, while not a classical GIRK channel, the Kir2.3 channel has been reported to 
be inhibited by G (Cohen, Sha et al. 1996). This is divergent from GIRK channels which are 
activated by the same G protein complex. The only known mechanism by which G-proteins inhibit 
Kir channels, is by GPCR activation of Gq which leads to depletion of the essential lipid PIP2  from 
the membrane. Gq activates phospholipase C, which converts PIP2 to diacylglycerol (DAG), and 
inositol triphosphate (IP3) (Kobrinsky, Mirshahi et al. 2000). As stated earlier, depletion of PIP2 
to leads to channel rundown and a reduction in channel activity. Thus, the mechanism of G 
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inhibition of Kir2.3 needs to be further explored as it was studied by expressing both proteins in 
Xenopus oocytes. 
An additional mechanism of Gq mediated inhibition of Kir2.1-2.3 channels was reported 
in vitro. Activation of the M1 receptor was found to reversibly inhibit all Kir2 subtypes. When 
cells were loaded with guanosine 5’-O-(2-thiodiphosphate) GDPS which blocks – GTPase 
hydrolysis, the effects of M1 receptor activation was attenuated. At this point classical knowledge 
would suggest G signaling as shown in Fig 1.2, however the study found that the small GTPase 
Rho mediated the inhibition of the Kir2.x channel (Jones 2003, Rossignol and Jones 2006). 
Transfection of an activated Rho GTPase reduced current density, which could be inhibited by a 
selective inhibitor of Rho, exoenzyme C3 transferase from Clostridium botulinum. This 
mechanism was found to be calcium dependent, and it is thought that M1 mediated calcium release 
leads to Rho GTPase activation and thus inhibition of Kir2.x channels. The study however did not 
carefully link calcium release to Rho activation, and only chelators of calcium were used to show 
diminished channel activity. The M1 Gq mediated release of calcium occurs through PLC 
generation of IP3 which activates calcium channels on the endoplasmic reticulum. Inhibitors of 
PLC would contribute to further establishing a link between M1 and Kir2.x channels. Additionally, 
Rho GTPases are a family of small guanine nucleotide binding proteins of which Ras, Cdc42/Rac 
and RhoA are extensively studied. The inhibitor of Rho, exoenzyme C3 transferase, used in the 
study blocked all Rho GTPases. Cdc42/Rac is reportedly activated by elevation of intracellular 
calcium within HEK293T cells (Jin, Guan et al. 2005). It is therefore likely that Kir2.x channels 
are inhibited specifically by Cdc/Rac which has not been directly tested. Rho GTPases also do not 
require receptor activation for function, so other activities in the cell which upregulates Rho 
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GTPase signaling can also affect Kir2.x channel activity. Whether Rho GTPases have an effect on 
other Kir family channels is unknown. 
Other proteins have also been reported to interact with GIRK channels when found in 
complex with GPCRs. The GABABR GPCR  signals to GIRK channels within neurons of the 
hippocampus. GABABR-GIRK signaling can be negatively modulated by regulators of G protein 
signaling (RGS) proteins (Olga, Keqiang et al. 2014). These proteins have been shown to increase 
the rate of G protein inactivation. Specifically, loss of RGS7 was found to result in a slower rate 
of deactivation of GIRK channels. Additionally, loss of R7BP, a membrane targeting RGS subunit 
caused additional reductions in channel deactivation. RGS7 has also been shown in vitro to exist 
in complex with GIRK channels (Zhou, Chisari et al. 2012). The RGS7 and R7BP proteins require 
the atypical G-protein G5 for function. Loss of G5 also leads to loss of RGS7 expression in 
mice (Xie, Allen et al. 2010). G5 has been shown to form complexes with RGS7, and GIRK1. 
G5 is able to bind to all GIRKs except GIRK4 which is typically found in the heart. Specifically, 
while RGS7/ G5 forms complex with GIRK channels, the presence of R7BP enhances formation 
of the complex (Zhou, Chisari et al. 2012). R7BP is thought to be a scaffold by some, where the 
palmitoylated protein is anchored to the membrane supporting the RGS7/Gβ5 interaction with the 
channel (Zhou, Chisari et al. 2012). The binding site of Gβ5 on GIRKs is similar to that of Gβ, 
but both the RGS7/Gβ5 complex and Gβ can both bind non-competitively to the channel (Zhou, 
Chisari et al. 2012). Thus, control of GIRK channel activation kinetics is regulated by the RGS 
proteins and Gβ, which both interact directly with the channel. 
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Scaffolding proteins and other interactions 
 In neurons, many ion channels are located at synaptic densities. The trafficking of 
proteins to these regions is supported by anchoring and scaffolding proteins. These anchoring 
proteins interact with the cellular cytoskeleton to target membrane proteins to key areas of the cell. 
Many of these anchoring proteins typically contain PDZ domains. PDZ domains are small regions 
consisting of beta-stranded and 2 or 3 alpha helical protein structures (Lee and Zheng 2010). These 
regions serve as binding sites for target proteins which are being “anchored” to a discrete region 
of the cell. One such anchoring protein is postsynaptic density protein 95 (PSD-95). PSD-95 is 
found in the post synaptic densities of neurons as the name suggest and is crucial to the clustering 
of channels and receptors at the post synaptic membrane. Loss of PSD-95 leads to a breakdown of 
the post synaptic density (Chen, Nelson et al. 2011). Kir2.3 ion channels have been observed by 
electron microscopy in the post-synaptic density of dendritic spines (Inanobe, Fujita et al. 2002). 
It was later found that Kir2.1 and Kir2.3 co-localize with PSD-95 in hippocampal neurons (Cohen, 
Sha et al. 1996). The C -terminal tail of the ion channel was found to be critical for this interaction. 
In the presence of PSD-95 these ion channels were observed to form clusters within the cell. 
Phosphorylation of Kir2.3 by PKA at a C terminal serine dissociates the interaction with PSD-95 
which suggest regulation of the interaction (Cohen, Sha et al. 1996). Kir5.1, which typically 
requires co-assembly with Kir4.1 to form functional channels, was also observed to colocalize 
with PSD-95 at the postsynaptic density in neurons (Tanemoto, Fujita et al. 2002). In cultured 
cells, when Kir5.1 was co-expressed with PSD-95, functional homomeric channels were formed 
which clustered at the membrane. In the absence of PSD-95 channels were mostly distributed 
intracellularly. It was further shown that PSD-95 facilitates surface expression of Kir5.1. Indeed, 
as Kir5.1 channels are typically found as hetero-tetramers with Kir4.1, Kir4.1 expression has also 
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been shown to induce Kir5.1 localization at the membrane (Tanemoto, Abe et al. 2014). Thus, 
Kir5.1 is able to form functional channels in the absence of Kir4.1 when PSD-95 is expressed. 
 Anchoring proteins also function in other cells besides neurons to target Kir channels. 
The Channel-interacting PDZ domain protein (CIPP) expressed in the brain and kidney was found 
to interact with Kir4.1 channels and to promote clustering at the membrane (Kurschner, 
Mermelstein et al. 1998). Kir4.1 channel activity doubled when CIPP was co-expressed in cultured 
cells. Membrane associated guanylate kinase with inverted domain structure-1 (MAGI-1) is 
another anchor protein essential to basolateral membrane expression of Kir4.1/5.1 channels in 
tubular cells of the kidney (Tanemoto, Abe et al. 2014). Mutations in Kir4.1 that lead to renal salt 
wasting dissociate MAGI-1 from Kir4.1/5.1 channels reducing basolateral membrane expression. 
 Kir 2.3 interacts with tax-interacting protein-1 (TIP-1) in concert with Lin-7. These two 
PDZ domain anchoring proteins regulate trafficking of the channel from the membrane to the 
endocytosis pathway (Yan, Zhou et al. 2009). Likewise, Kir1.1 was found to interact with PDZ 
domain containing Na/H exchange regulatory factors (NHERF1/2) in the kidney (Yoo, Flagg et 
al. 2004). NHERF increases the surface expression of Kir1.1 and facilitates coupling with CFTR 
in formation of CFTR/Kir1.1 KATP channels. 
 As mentioned previously, Kir phosphorylation occurs via PKA or PKC. The targeting of 
PKA to subcellular locations occurs by interaction with A Kinase-anchoring proteins (AKAPs). 
Kir2.1 channels have been shown to associate with AKAP79/5 at the membrane (Dart and Leyland 
2001). AKAPs thereby maintain kinase substrates in close proximity which allows efficient tuning 
of ion channel activity.  
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Figure 1.2 Known protein-protein interactions of inward rectifying potassium channels. 
 
Diagram depicts various proteins known to interact with different Kir channels and their relative 
cellular locations. GPCRs typically couple to GIRK channels which are activated by G and 
tuned by the RGS7/G5 complex. When GPCRs are switched off, GIRK channels can also be 
internalized with the receptor by arrestin binding and recruitment of clathrin (not shown). KATP 
channels are composed of Kir6.2 and the SUR1 receptor. Kir2.x can also be regulated G to cause 
channel closure, and also by RhoGTPase. Kir channels also interact with scaffolding proteins 
through interaction with PDZ domains present on many of these proteins (listed). These proteins 
support trafficking of different channels through the cell (see section “scaffolding proteins and 
other interactions”). AKAPs also associate with Kirs to maintain PKA and PKC in close proximity. 
These phosphorylate the channel to regulate activity.  
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MC4R, the first G protein-coupled receptor reported to functionally interact with Kir7.1 
 Energy homeostasis is an essential physiological function that is tightly regulated. It 
controls the drive for food intake, and also promotes energy expenditure. Dysregulation in this 
system can lead to obesity or symptoms of anorexia. Central to the control of energy balance are 
the melanocortin peptides which act on MC4 receptors throughout the CNS (Poggioli, Vergoni et 
al. 1986). Specifically, these peptides cleaved from the precursor protein proopiomelanocortin 
(POMC), are endogenous agonist for the G protein-coupled melanocortin receptors. Within the 
family of five melanocortin receptors, the MC4R plays key roles in energy homeostasis (Cone 
1999). MC4R Knockout mice were found to display early onset obesity with increased linear 
growth, hyperphagia and decreased energy expenditure (Huszar, Lynch et al. 1997). It was also 
shown that MC4R displays gene dosage effects, wherein mice with one copy of the gene display 
an intermediate phenotype. MC4R’s role in energy homeostasis is also highly conserved across 
multiple species (Logan, Bryson-Richardson et al. 2003, Aspiras, Rohner et al. 2015). Ultimately, 
MC4R was found to regulate feeding, where activation of the receptor by its endogenous agonist 
-MSH reduced the drive for food intake, and increased energy expenditure. The molecular 
mechanisms governing the signaling of MC4R is of keen interest, providing a possible avenue for 
obesity and cachexia treatments. 
 MC4R was first cloned in 1993, based on homology to previously discovered family 
receptors MC1R and MC2R (Mountjoy, Robbins et al. 1992, Gantz, Konda et al. 1993). The 
receptor was profiled and found to couple to the G stimulatory protein (GS), which leads to the 
downstream upregulation of cAMP (Fig 1.3). An endogenous inverse agonist agouti-related 
peptide (AgRP) acts to inhibit the receptor and reduce cAMP generation. GPCRs have also been 
shown to signal to different G proteins and can thus activate different signaling pathways. As 
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MC4R activation leads to multiple physiological effects, whether GS mediates all these responses 
has been the goal of many studies. Deletion of GS within MC4R neurons mimicked the MC4R 
knockout obesity phenotype with hyperphagia and increased food intake (Podyma, Sun et al. 
2018). Gq and G11 are two other heterotrimeric G proteins which activate phospholipase C and 
increase intracellular calcium levels (Fig 1.3). Calcium can act as a second messenger within 
neurons with multiple downstream effects. Deletion of Gq and G11 from the paraventricular 
nucleus of the hypothalamus (PVN) where MC4R controls food intake, also led to obesity, 
hyperphagia and increased linear growth (Li, Shrestha et al. 2016). Interestingly, an MC4R agonist 
Melanotan-II (MTII) was unable to reduce food intake in PVN Gq/11 KO mice, but did reduce 
food intake in PVN GsKO mice.  Additionally, MC4R affects sympathetic nervous system output, 
with agonist activation increasing blood pressure. In PVN Gq/11 KO mice, MTII increased systolic 
blood pressure, whereas it failed to have a response in PVN Gs KO mice (Li, Shrestha et al. 2016). 
These data indeed suggest that multiple signaling pathways are activated after MC4R stimulation 
by 𝛼-MSH, which then mediate different physiological effects. 
 GPCRs like MC4R also lead to arrestin recruitment after receptor activation and G-
protein signaling.  The binding of arrestins to the phosphorylated C terminal region of the receptor 
switches off further G-protein signaling. Arrestins not only target the GPCR for internalization, 
but also facilitate G-protein independent receptor signaling (Luttrell, Gesty-Palmer et al. 2010). 
Arrestins can couple to the mitogen activated kinase pathway (MAPK), that signals downstream 
to effects like transcriptional regulation. Biased ligands are actively being developed that can 
stimulate MC4R to signal via the G protein only or arrestin only pathways. Given the various 
downstream effects of the receptor, these tools can be useful to differentiate the physiology 
associated with a particular signaling pathway.  
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Figure 1.3 Signaling pathways and interacting proteins of MC4R 
-MSH and AgRP binding to MC4R lead to the activation of different signaling pathways. The G 
protein and arrestin signaling pathways of the receptor are shown. Additionally, MC4R is known 
to interact with the melanocortin 2 receptor associated protein 2 (MRAP2). Attractin, mahogunin 
(MGRN1) and tumor suppressor gene 101 (Tsg101) involved in receptor internalization are also 
shown. PLC- phospholipase C. Figure adapted and modified from Anderson et al 2016, Journal of 
Molecular Endocrinology. Original figure created by Taneisha Gillyard. Reproduced with 
permission. See appendix page 89. 
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 MC4R neuronal circuitry has been mapped within the hypothalamus and other regions of 
the brain. MC4R expression in the central nervous system (CNS) extends to both the sympathetic 
and parasympathetic systems (Sohn, Harris et al. 2013). In the brainstem, MC4R activity was 
linked to obesity related hypertension and increased sympathetic activity (Hill and Faulkner 2017). 
Indeed, loss of MC4R in mice was also recently shown to be associated with cardiomyopathy (Litt, 
Okoye et al. 2017). Many small molecules targeting MC4R to treat obesity have shown promise 
in mouse studies, but failed in the clinic due to a pressor side effect (Greenfield, Miller et al. 2009). 
However, setmelanotide (RM-493) a cyclic peptide has been identified in clinical studies to  avoid 
the pressor side effect (Chen, Muniyappa et al. 2015).  This compound maintains MC4R 
stimulatory activity and mediates modest weight loss (Collet, Dubern et al. 2017). At the molecular 
level, the mechanism by which setmelanotide can mediate some effects of MC4R but not others is 
yet to be determined.  If individual pharmacological signaling pathways of the receptor can be 
mapped to specific physiological responses, the case for biased ligands becomes increasingly clear 
to treat specific disruptions in energy balance. 
 To study the role of MC4R within the PVN, Ghamari-Langroudi et al recorded from 
MC4R expressing neurons. They noticed that bath application of -MSH led to robust neuronal 
depolarization, with the endogenous inverse agonist AgRP hyperpolarizing the neuron. GPCRs are 
known to mediate neuronal signaling by coupling to ion channels on the cell membrane. 
Particularly, inwardly rectifying potassium channels like Kir3.x channels can be activated by 
GPCRs via G proteins to control neuronal activity. However, using a panel of inhibitors against 
Kir channels, Kir7.1 was identified as the inward rectifier mediating -MSH induced neuronal 
depolarization. Specifically, MC4R activation leads to Kir7.1 closure causing neuronal 
depolarization, whereas AgRP promotes channel opening leading to membrane hyperpolarization. 
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MC4R mediated closure of Kir7.1 was also shown to occur independently of G proteins (Fig 1.4A). 
This finding was indeed surprising, and it identified a potential new mechanism of GPCR signaling 
to ion channels. Kir7.1 does not fall under the category of G protein inwardly rectifying potassium 
channels (GIRK, Kir3.x) which typically couple to GPCRs. Thus, the exact mechanism of 
interaction is unknown. 
With Gs signaling shown in KO studies to be essential to MC4R’s role as an energy 
rheostat, the physiological role of MC4R-Kir7.1 signaling was yet to be determined. Anderson et 
al created mice with MC4R specific deletion of Kir7.1 within hypothalamic neurons. This method 
was needed as global Kir7.1 knockout is embryonically lethal (Zhong, Chen et al. 2015). In PVN 
slice preparations, 𝛼-MSH failed to induce neuronal depolarization in mice lacking Kir7.1 in 
MC4R expressing cells (Fig 1.4B). This experiment confirmed the Kir7.1 dependent signaling 
pathway of MC4R. Phenotypic profiling also showed that these mice had late onset weight gain 
compared to WT controls, though not as significant as MC4R KO mice (Fig 1.5). Additionally, 
these mice also had an attenuated response duration to an MC4R peptide agonist LY2112688 to 
reduce fast induced refeeding compared to controls. These results support a role for the Kir7.1-
MC4R pathway in energy homeostasis. With this new data, ultimately three pathways of MC4R 
have been physiologically profiled (MC4R-Gs, MC4R-Gq/G11, MC4R-Kir7.1). 
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Figure 1.4. MC4R specific deletion of Kir7.1 in PVN neurons leads to defective -MSH induced 
depolarization. 
Electrophysiology recordings from slices of PVN MC4R-GFP positive neurons. A. Recordings 
from control mice expressing Kir7.1 (KCNJ13), with bath application of -MSH inducing action 
potentials. B. Slices from KCNJ13ΔMC4RCre mice display significantly diminished action 
potentials when -MSH is applied. Bar graph represents mean of 15-35 cells (P<0.0001). Data 
adapted from Anderson et al 2018, Journal of Neuroendocrinology. Reproduced with permission. 
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Figure 1.5. Mice lacking Kir7.1 in MC4R PVN neurons develop late onset obesity. 
A-B. Growth curves of A (male) and B (female) controls (Kcnj13+/+;MC4R+/+,  Kcnj13fl/fl , 
Kcnj13+/+;MC4RCre) versus Kcnj13ΔMC4RCre mice. C-D. Snout to anus length linear growth of C 
(male) and D (female) mice from groups shown in A-B measured at age 30 weeks. 6-25 mice per 
group, **P<0.005, ****P<0.0001. Data adapted from Anderson et al 2018, Journal of 
Neuroendocrinology. Reproduced with permission. 
 
 
 
Though a new MC4R pathway involving Kir7.1 was identified, this ion channel has not 
been extensively profiled. Kir7.1 was first identified as a small unitary conductance Kir channel 
in 1998 with 37% identity to other inward rectifiers (Doring, Derst et al. 1998). Kir7.1 is highly 
expressed in the brain, specifically the choroid plexus. Expression in the PVN was confirmed by 
dual fluorescence in situ hybridization, though very low levels were found to be present (Ghamari-
Langroudi, Digby et al. 2015). Roles for Kir7.1 have been demonstrated in the kidney and uterus, 
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with the retinal pigment epithelium being the area of greatest study (Suzuki, Yasuoka et al. 2003, 
McCloskey, Rada et al. 2014, Zhong, Chen et al. 2015).  In the eye, Kir7.1 helps to maintain 
potassium homeostasis working in concert with the NaKATPase pump in the subretinal space 
(Kumar and Pattnaik 2014). Mutations within this ion channel lead to channelopathies such as 
Snowflake Vitreoretinal Degeneration (SVD) that result in various forms of blindness (see Chapter 
IV). Kir7.1 also supports potassium excretion in the Kidney where it is expressed in the medulla 
but not the cortex (Cornejo, Villanueva et al. 2018). While Kir7.1 is expressed in the trachea and 
testis, its function there has not been widely studied. 
 
Research objective 
 With a physiological role for the MC4R-Kir7.1 interaction identified, determining the 
molecular mechanism of how this interaction occurs remains of keen interest. With a goal to 
develop therapeutics to treat disorders of energy homeostasis, understanding how these two 
proteins interact is of great importance. MC4R and Kir7.1 have also been shown to associate via 
co-immunoprecipitation as a complex in HEK293T cells (Ghamari-Langroudi, Digby et al. 2015) 
(See Chapter III, Fig 3.8). The functional coupling observed in the slice has also been reproduced 
in vitro using a fluorescence based assay (Ghamari-Langroudi, Digby et al. 2015, Litt, Cone et al. 
2017). Given than MC4R can show signal bias with different ligands, one goal is to identify 
MC4R-Kir7.1 biased ligands in an attempt to avoid the pressor side effect. In our efforts to develop 
screening assays for these compounds, we discovered that other GPCRs may also associate with 
Kir7.1. The goal of this work, was to determine how Kir7.1 is regulated at a molecular level by 
protein-protein interactions with GPCRs. We discovered that channel glycosylation plays an 
essential role in Kir7.1 function, and that GPCRs can differentially regulate its degree of 
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glycosylation (Carrington, Hernandez et al. 2018). With Kir7.1 having different physiological 
roles across tissues, it is increasingly important to understand how this ion channel is controlled at 
the molecular level. This dissertation describes these new mechanisms of Kir7.1 regulation. 
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CHAPTER II 
 
GLYCOSYLATION REGULATES FUNCTION OF INWARD RECTIFIER CHANNEL 
KIR7.1 
 
 
Sheridan J. Carrington, Ciria C. Hernandez, Daniel R. Swale, Oluwatosin T. Aluko Jerod S. 
Denton3,4, and Roger D. Cone 
 
This chapter was published as part of Carrington et al 2018, JBC  
“G protein–coupled receptors differentially regulate glycosylation and activity of the inwardly 
rectifying potassium channel Kir7.1” 
 
 
Abstract 
 
Kir7.1 is an inwardly rectifying potassium channel with important roles in the regulation of 
membrane potential in retinal pigment epithelium, uterine smooth muscle, and hypothalamic 
neurons. Potassium channels undergo post translational modifications which can either promote 
or suppress function. Like other inward rectifiers, Kir7.1 was found to be glycosylated with both 
core and complex glycosylation. The only active glycosylation site of Kir7.1 was identified as 
N95, and a glycosylation resistant mutant of the channel N95Q was tested for an effect on function. 
Glycosylation was found to be essential for channel function, with the N95Q mutant displaying 
lower current amplitudes and reduced open states in single channel recordings. Mutation of a 
shared canonical Golgi export site present in Kir7.1 also led to a loss of complex glycosylation. 
Additionally, we found that the L241P mutation of Kir7.1 associated with Lebers congenital 
amaurosis (LCA), an inherited retinal degenerative disease, has significantly reduced complex 
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glycosylation. These results support the proposal that Kir7.1 requires glycosylation for channel 
function in tissues where it is expressed. 
 
Introduction 
 
Kir7.1, encoded by the Kcnj13 gene, is a two-transmembrane domain potassium channel, 
closest in homology to Kir channels associated with potassium transport such as Kir1.1, 4.x, and 
5.1(Hibino, Inanobe et al. 2010). In comparison to other channels, Kir7.1 exhibits a small unitary 
conductance, and low dependence on external potassium (Doring, Derst et al. 1998). This was 
shown to be due to the presence of a methionine at position 125 in the pore, where other Kir 
channels have an arginine. Mutation of this residue to arginine was found to mimic/restore the 
conductance and potassium dependence observed in like-family channels (Doring, Derst et al. 
1998). Kir7.1 is widely expressed, but particularly high expression has been reported in the retinal 
pigment epithelium (RPE), thyroid, uterine smooth muscle, small intestine and choroid plexus of 
the brain (Nakamura, Suzuki et al. 1999, Yang, Pan et al. 2003). 
Until recently, Kir7.1 was primarily studied within the RPE.  In RPE cells, Kir7.1 is found 
in the apical membrane close to photoreceptor neurons, where it is thought to contribute to ion 
homeostasis (Pattnaik, Tokarz et al. 2013). Mutations in Kir7.1 lead to snowflake vitreoretinal 
degeneration (SVD) and Leber congenital amaurosis (LCA), which are both retinal dystrophies 
(Hejtmancik, Jiao et al. 2008, Sergouniotis, Davidson et al. 2011, Zhang, Zhang et al. 2013, Khan, 
Bergmann et al. 2014, Pattnaik, Shahi et al. 2015). In jaguar/obelix zebrafish, mutations in Kir7.1 
produces spotted pigment patterns rather than stripes, and also results in a failure of melanosomes 
to respond to changes in light (Iwashita, Watanabe et al. 2006). These functional mutations of 
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Kir7.1 in RPE cells and melanocytes have been characterized and shown to cause alterations in 
channel currents resulting in the described pathologies.  
 Glycosylation of proteins has been widely studied and can have various effects on protein 
function from supporting protein folding, to ensuring surface expression. Glycosylation begins co-
translationally in the ER where the first glycan is added, and is completed in the Golgi complex 
with the addition of complex glycans. In the case of N-linked glycosylation, the first core glycan 
is added by a complex of enzymes to an accessible asparagine residue with the protein sequence 
Asn-X-Ser/Thr (Aebi 2013). ER added glycans are then pruned in the Golgi before the addition of 
more complex structures. Proteins with ER only glycans are referred to as immature or core-
glycosylated, and those with more complex Golgi added structures are termed mature or complex 
glycans. Glycans added to the protein in the Golgi are resistant to the endoglycosidase Endo H, 
but core glycans are sensitive. This can be exploited to probe the protein trafficking and maturation 
of glycosylated proteins. 
 A role for glycosylation in Kir channels has not been widely studied with only a few 
channels reported to have glycosylation. Kir1.1 remains the only channel for which glycosylation 
was found to have a role in function, with a glycosylation mutant tested having reduced channel 
open probability (Schwalbe, Wang et al. 1995). While other channels such as Kir3.x and Kir4.1 
are glycosylated, glycans are either not essential for function or a role in function has not been 
tested. Among inward rectifiers, a role for Kir7.1 has been mainly studied in the RPE, and how 
variants of the channel affect function and cause retinopathies. On the molecular level, it remains 
unclear how certain posttranslational modifications of Kir7.1 may affect channel function. While 
phosphorylation of the channel has been previously described, glycosylation of Kir7.1 and its role 
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in channel function has yet to be determined (Zhang, Zitron et al. 2008). Here, we describe 
characterization of the sole glycosylation site in Kir7.1. 
 
Results 
 
Kir7.1 undergoes complex glycosylation 
To overexpress 3xFLAG tagged Kir7.1 in mammalian cells, we used a construct of the 
human cDNA sequence inserted into a pciNeo plasmid. Transient expression of the channel in WT 
HEK 293T cells led to three predominant bands observed, with the lowest band migrating as a 
doublet (Fig. 2.1). Using endoglycosidases, we confirmed the upper 50kDa band as the Endo H 
resistant mature/complex glycosylated form of the channel, indicating that these bands are Kir7.1 
that include glycans added in the Golgi complex. With Endo H treatment, the 37kDa doublet 
shifted to a single band, indicating Endo H sensitivity. As Endo H sensitive glycans are added in 
the endoplasmic reticulum, we identified this upper 37kDA band as the core glycosylated form, 
and classified this lower band as the unglycosylated form of Kir7.1. Additionally, treatment with 
the glycosidase PNGase F, which cleaves all asparagine linked (N) glycans of proteins, confirmed 
that the single migrating band at 37kDa is the unglycosylated protein, and that Kir7.1 glycosylation 
is N-linked. 
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Figure 2.1 Inhibition of complex glycosylation of Kir7.1 by the β2AR.  
Western blot analysis of Kir7.1 whole cell lysates untreated, or treated with Endo H or PNGase F. 
Enzymatic treatment identified the 50KD Endo H resistant doublet as the complex or mature 
glycosylated form (Lane 2).  The 37KD band was identified as the core glycan form due to endo 
H sensitivity (lane 2), and the lowest band in lane 3 as the un-glycosylated PNGase F cleaved 
form. Representative of three independent experiments. 
 
Lack of glycosylation of Kir7.1 alters channel gating 
Within the Kir family, the functional role of glycosylation has been studied for ROMK 
(Kir1.1) and GIRK1 (Kir3.1) (Pabon, Chan et al. 2000). While loss of glycosylation at Asn119 in 
GIRK1 was reported not to be required for function, loss of glycosylation at Asn117 in ROMK1 
reduced open channel probability, and whole cell currents (Schwalbe, Wang et al. 1995). 
Additionally, though Kir3.4 is reported to have an asparagine accessible for glycosylation, the site 
was found to be inactive (Pabon, Chan et al. 2000). Thus, divergent roles for glycosylation exist 
within the family. Based on these studies, we aligned the Kir7.1 protein sequence with ROMK and 
GIRK1 and determined that Kir7.1 also shared a highly conserved glycosylation site (Fig. 2.2A). 
Kir7.1 also shared the canonical sequence associated with N-linked glycosylation- N-X-T/S, where 
Kir7.1 has a Threonine in the third position. We mutated this site to a glutamine (Kir7.1-N95Q) 
and confirmed by western blot analysis the loss of both core and complex forms of glycosylation 
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(Fig. 2.2B). Furthermore, we generated a model of Kir7.1 based on the Kir2.2 crystal structure 
using SWISS_MODEL, which revealed the likely glycosylation site to be in the outer loops gating 
the pore (Fig. 2.2C). This was suggestive of a functional role for glycosylation in Kir7.1. To assess 
this, we performed single channel recordings using the M125R mutant of Kir7.1, to compare the 
WT fully glycosylated channel (Kir7.1-M125R), to the un-glycosylated mutant channel (Kir7.1-
M125-N95Q).  
Wild type Kir7.1 displayed clusters of openings with a main amplitude level of ~1 pA (Fig. 
2.3A, 3D). Lack of glycosylation at the N95 position of Kir7.1 channels caused openings to occur 
at an amplitude level of ~0.6 pA (N95Q = 0.65 ± 0.03 pA, n=6; wt = 1.11 ± 0.07 pA, n=7. 
P=0.0001) with a reduced open probability (N95Q = 0.23 ± 0.05, n=6; wt = 0.41 ± 0.06, n=7. 
P=0.0484) (Fig. 2.3B, 2.3E). Both channels opened to at least three open states (O1, O2 and O3), 
with no changes in the relative occurrence of opening events (N95Q = 9.09 ± 3.8 ms, n=6; wt = 
17.9 ± 3.5 ms, n=7.n p=0.1188). Thus, the lack of glycosylation l leads to a clear reduction in 
function of individual Kir7.1 channels. 
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Figure 2.2 Creation of an unglycosylated mutant of Kir7.1.   
A. Lasergene MegAlign software was used to confirm Kir7.1 conserved glycosylation site of N95 
compared to other known glycosylated Kir channels, ROMK(Kir1.1) N117 and GIRK1 N119 
(Pabon, Chan et al. 2000). This site also has a known N-linked glycosylation sequence (N-X-T/S) 
(Helenius and Aebi 2004). B. The N95 site of Kir7.1 was mutated to glutamine N95Q, and the 
whole cell lysates of the 3xFLAG tagged N95Q mutant and the similarly tagged WT channel were 
analyzed by western blot analysis using an anti-flag antibody. No higher migrating forms of Kir7.1 
were observed in the N95Q mutant. C. Homology modeling of Kir7.1 based on Kir2.2 (PDB 5kuk) 
revealed the location of the N95 site in the outer loops which gate the channel pore. This suggested 
a possible role for glycosylation in channel function. Modeling performed using SWISS-MODEL, 
and image generated with PyMOL. Transfection levels were as in Figure 2.1. 
  31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.3 Representative single-channel current traces from cell-attached patches of Kir7.1  
 Kir7.1-M125R (A) and Kir7.1-M125RN95Q (B) channels recorded from HEK293T cells. Patches 
were voltage clamped at 130 mV. Openings are downward and each representative trace was a 
continuous 5000-ms recording. (C) Average time histograms of openings (O1, O2 and O3) events 
are shown with the time constants (ms) and the relative contribution (%) of open events. Bar graphs 
summarize the effects of Kir7.1-M125RN95Q on amplitude (D), mean open probability (NPo) (E), 
and mean open time (F) of channels. Values are expressed as mean ± S.E.M (WT, N = 6; NQ, N 
= 7).  Statistical differences were determined using unpaired t-test relative to wt. C and O refer to 
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the closed and open states, respectively. Wt, wild type. NQ, N95Q. Experiment performed by Ciria 
C. Hernandez 
 
Kir7.1 has a conserved Golgi export site, essential for complex glycosylation 
With recent reports of a Golgi export site required for surface expression of Kir channels 
(Ma, Taneja et al. 2011, Li, Ortega et al. 2016), we found that Kir7.1 shared a similar site to the N 
and C terminal regions of Kir2.1, 4.1, and 5.1 that has been identified as essential for Golgi export 
(Fig. 2.4A-B) (Li, Ortega et al. 2016). Within the channels mentioned, deletion of the serine and 
tyrosine (SY) residues within the C-terminal site was found to be sufficient to prevent Kir export 
from the cis-Golgi and trans-Golgi compartments of the cell, where complex glycosylation takes 
place (Ma, Taneja et al. 2011, Li, Ortega et al. 2016). Additionally, while WT Kir2.1 is not 
glycosylated, it was reported that deletion of SY in Kir2.1 also reduced complex glycosylation of 
an artificially placed asparagine residue (Ma, Taneja et al. 2011). Given the apparent conservation 
of this site in Kir7.1, we tested whether deletion of these residues would alter WT Kir7.1 
glycosylation. Deletion of the SY motif in Kir7.1 led to a significant loss of complex glycosylation 
with a ratio of <0.1 in Cos1 cells (Fig. 2.4 C-D).  We established a metric for the proportion of 
Kir7.1 complex glycosylation, by determining the ratio of mature/complex glycosylation, to 
immature core glycosylated plus unglycosylated forms of the protein. Cos1 cells were used, as 
published studies of the export site in other Kir channels were performed in Cos cell-lines (Grieve 
and Rabouille 2011).  We further confirmed the loss of complex glycosylation by endoglycosidase 
digestion using Endo H and PNGase F (Fig. 2.4E). This indicates that the Golgi export residues 
SY in Kir7.1 are essential for complex glycosylation of Kir7.1. While the SY mutant did have a 
significantly low glycosylation ratio, we also observed a glycosylation ratio of <0.8 in the WT 
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channel in Cos1 cells (Fig. 2.4E), lower than the typical ratio of 1 observed in HEK293T cells (see 
Fig.1.2 chapter III). 
 
 
Figure 2.4 A conserved Golgi transport signal is required for complex glycosylation of Kir7.1.  
A. Schematic showing a two pore domain Kir channel subunit with two transmembrane regions 
M1 and M2. The consensus N terminal and C terminal Golgi export patch residues are shown, 
with known essential residues shown in red. Clustal alignment of the N and C terminal regions of 
the Golgi export patch of other closely related Kir channels which have been previously identified 
(Li, Ortega et al. 2016). Kir7.1 shares a highly conserved patch, except for a C terminal leucine 
residue where other channels have a tryptophan. B. SWISS-Model of Kir7.1 structure based on 
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the crystal structure of Kir2.2 (PDB5KUK). Blue highlighted regions show the glycosylation site 
in each monomer of the channel. The N and C terminal portions of the Golgi export patch are 
highlighted in green and red respectively. C. Deletion of the serine and tyrosine residues in the 
Golgi export patch of Kir7.1 led to a loss of complex glycosylation compared to the WT channel 
determined by western blot analysis in Cos1 cells. D. Compared to the WT channel, essentially no 
complex glycans were observed indicated by the significantly low ratio of 0.1  p<0.005, (unpaired 
t-test).  E. Enzymatic digestion of whole cell lysates of the WT versus Kir7.1 SYΔ mutant from 
HEK293T cells confirmed only the immature forms of Kir7.1 are expressed. Data analyzed from 
four independent experiments analyzed in Graphpad Prism, with one-way ANOVA. Error bars for 
all data represents S.E.M. 
 
Kir7.1 forms heterotetramers of immature, unglycosylated, and fully glycosylated subunits 
 
 Having established that complex glycosylation of Kir7.1 is required for function, we 
tested whether the channel exists as homo- or hetero-tetramers of subunits with no glycosylation, 
core glycosylation, and complex glycosylation. We co-expressed flag tagged Kir7.1-N95Q or 
Kir7.1SY with an HA tagged WT Kir7.1 channel. HA tagged WT Kir7.1 co-immunoprecipitated 
with both the un-glycosylated (N95Q) and immature glycosylated (SY) forms of the channel, in 
addition to the fully glycosylated WT control (Fig. 2.5). This suggests that non-functional Kir7.1 
subunits may form tetramers with WT subunits, and thus may reduce channel function through 
“subunit poisoning”. Theoretically, a threshold may exist where a minimum number of subunits 
must be fully glycosylated in order for the channel to be functional. Thus, the presence of an 
unglycosylated subunit may indeed poison the entire tetramer functionally, similar to a dominant 
negative mutant. This however has not been definitively tested. 
 
Retinopathy associated mutations of Kir7.1 also alter channel glycosylation 
 Genetic studies have linked retinopathies of the eye to mutations in Kir7.1, demonstrating 
that Kir7.1 plays a key role in the function of the retinal pigment epithelium.  Snowflake 
Vitreoretinal Degeneration (SVD) and Lebers Congenital Amaurosis (LCA) are two Kir7.1 
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associated hereditary eye disorders, where known variants of Kir7.1 lead to loss of channel 
function (Kumar and Pattnaik 2014). We wanted to determine if glycosylation is also affected by 
any of these disease mutations, and a few known variants of Kir7.1 namely R162W, R162Q, 
Q117R, and L241P were tested. These are all considered to be loss of function mutations, except 
R162Q which is linked to blindness, but has no reported phenotype (Kumar and Pattnaik 2014). 
Notably, none of these mutations are in known sites required for complex glycosylation. 
Interestingly, we observed a significant reduction in glycosylation in the L241P mutation (Fig 2.6), 
in addition to reduced levels of protein expression.  
 
 
Figure 2.5 Kir7.1 forms heterotetramers of immature and unglycosylated subunits. 
HEK293T cells were transiently transfected with HA-Kir7.1 with either flag tagged Kir7.1 
N95Q, Kir7.1 SY or Kir7.1 WT as a control; transfection levels were as in Fig. 2.1. Cell lysates 
were immunoprecipitated with an HA antibody and immunoblotted with anti-flag.  Blot is 
representative of three independent experiments. See methods for additional experimental 
details. 
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Figure 2.6.  A retinopathy associated variant of Kir7.1 has altered complex glycosylation. 
A. Western blot analysis of three known variants of Kir7.1, following transfection of Kir7.1 
mutants indicated; transfection levels were as in Fig. 2.1. Whole cell lysates of HEK293T cells 
expressing a known variant of Kir7.1 were analyzed for changes in glycosylation. Kir7.1 L241P 
in lane 5 not only had lower expression, but the absence of complex glycosylation. *15ug of 
protein were loaded versus 7.5ug in all other lanes.  Blot is representative of four independent 
experiments. B. Densitometric analysis was performed to obtain the ratio of mature to immature 
glycosylation. Data representative of three independent experiments. P<0.0001 with one-way 
ANOVA. Error bars for all data represent S.D.. 
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Discussion 
 
 Glycosylation has been previously reported for two members of the same family of 
channels as Kir7.1, Kir1.1 (ROMK) and Kir3.1 (Pabon, Chan et al. 2000). Loss of glycosylation 
in Kir1.1 was shown to decrease whole cell currents due to a significant reduction in open channel 
probability (Schwalbe, Wang et al. 1995). We observed similar results in our N95Q glycosylation 
resistant mutant by single channel recordings. Interestingly, Kir3.1, though having an active 
glycosylation site, is not reported to require glycosylation for function. While Kir3.1 and Kir3.4 
form complexes, Kir3.4 has a consensus glycosylation site that is reported to be inactive (Pabon, 
Chan et al. 2000). Thus, within the two-transmembrane domain family of Kir channels, a divergent 
role for channel glycosylation exists.  Additionally, the Kir4.1 channel has been shown to be 
differentially glycosylated in different tissues. While higher amounts of complex glycosylation of 
Kir4.1 have been observed in kidney versus brain lysates, a functional role for glycosylation has 
not been investigated (Hibino, Fujita et al. 2004).  
Kir1.1 and ROMK have the highest similarity to inward rectifier to Kir7.1, with ~38% 
sequence homology. As mentioned previously, Kir1.1 is the only inward rectifier with a clear 
reported role for glycosylation. The N95 site in Kir7.1 appears structurally related to the N117 site 
in Kir1.1 which suggested a similar role for glycosylation in Kir7.1, as validated here. From 
sequence analysis, the glycosylation site of both these channels is present in the turret region of 
the channel, an extracellular loop before the pore helix between the two transmembrane domains 
(Shealy, Murphy et al. 2003). This region has high variability across the large potassium channel 
family, with a potential function for sensitivity to toxin binding (Shealy, Murphy et al. 2003). 
Based on our homology model of Kir7.1 (Fig. 2.2C), these extracellular loops would house the 
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relatively large glycans at N95, that by our estimate from western blot analysis are over 13kDa in 
size. However, the exact mechanism by which the presence of these glycans is essential for a fully 
functional channel is not clear. Structural comparison of the Kir7.1 model to the Kir2.2 crystal 
structure also shows that the turret region of Kir7.1 is longer than that in Kir2.2 with additional 
prolines present in the loop. These proline residues may introduce additional turns in the loop 
either towards or away from the pore. However, we were unable to predict these conformations 
with SWISS-MODEL. A crystal structure of this extracellular region of Kir7.1 would indeed allow 
us to develop an hypothesis for the mechanism by which glycosylation aids channel function.   
It was interesting to observe that the L241P LCA associated variant of Kir7.1 exhibited a 
near complete loss of complex glycosylation. This mutation has not been extensively studied, but 
the loss of channel function was predicted due to its association with LCA, a severe form of retinal 
degeneration (Zhang, Zhang et al. 2013). This mutation is thought to be in a  sheet of the protein, 
near the C-terminal region, and is predicted to affect protein folding. It remains unknown whether 
the change in structure is responsible for the loss of glycosylation and thus a loss of function, or a 
reduction in protein stability, or loss of activity due to another structural defect (Sergouniotis, 
Davidson et al. 2011). The protein did not express well following transfection of  HEK293 cells 
(Fig. 2.6), but data are not available to assess whether or not the mutation reduces expression levels 
in RPE cells in vivo. Both the WT and L241P Kir7.1 proteins have now been purified by Dr. Alys 
Peisley in the Cone laboratory, and their structures are being determined by Cryo-EM. 
We have observed that deletion of the serine and tyrosine resides within the Golgi export 
site of Kir7.1 also inhibits complex glycosylation, but leaves core glycosylation intact. The SY 
mutant of Kir7.1 described here may thus be a useful tool in future experiments to determine if 
core glycosylation is sufficient for maintenance of normal channel function. Complex 
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glycosylation is reported to occur at different stages during passage from the cis-medial-trans 
Golgi before export to the surface (Stanley 2011). Within other Kir channels, the Golgi export site 
has been identified as a binding site of the AP-1 gamma adaptin protein which is required for 
export to the cell surface (Ma, Taneja et al. 2011, Li, Ortega et al. 2016). In Kir2.1, deletion of 
these two residues reduced complex glycosylation of an artificial site placed within the channel by 
mutagenesis, with an intermediate glycosylation pattern observed (Ma, Taneja et al. 2011). They 
argue that as complex glycosylation occurs in the trans-Golgi network, loss of the export site traps 
Kir2.1 in both the cis and trans Golgi network, preventing further transport leading to incomplete 
complex glycosylation. However, in Li et al 2016, the authors comment that in comparison to other 
Kir channels, Kir7.1 is the only channel that does not seem to share the full export site. While we 
have confirmed the export site to be essential for complex glycosylation, these two residues do not 
appear to be required for Golgi export (data not shown), however, this was expected as we did see 
immature forms of the WT channel at the surface in biotinylation experiments  described in chapter 
III. 
Through sequence analysis and site directed mutagenesis we have shown that Kir7.1 
requires glycosylation for full channel function. Few antibodies exist that allow the detection of 
glycosylated forms of Kir7.1. However, as these studies were being completed a new HA-Kir7.1 
Crispr mouse model described by Cornejo et al 2018 was demonstrated to express highly variable 
levels of Kir7.1 complex glycosylation in different tissues. Thus, this animal model may be useful 
to study the physiological functions of Kir7.1 glycosylation in vivo.  
  40 
 
CHAPTER III 
 
GPCRS DIFFERENTIALLY ALTER THE COMPLEX GLYCOSYLATION OF KIR7.1 
 
 
Sheridan J. Carrington, Ciria C. Hernandez, Daniel R. Swale, Oluwatosin T. Aluko Jerod S. 
Denton3,4, and Roger D. Cone 
 
This chapter was published as part of Carrington et al 2018, JBC  
“G protein–coupled receptors differentially regulate glycosylation and activity of the inwardly 
rectifying potassium channel Kir7.1” 
 
 
Abstract 
 
Kir7.1 is an inwardly rectifying potassium channel which plays varying roles in potassium 
homeostasis. Recently, new roles are being discovered such as Kir7.1 coupling to the 
melanocortin-4 receptor (MC4R), a G protein–coupled receptor (GPCR) in hypothalamic neurons. 
Regulation of G protein–coupled inwardly rectifying potassium (GIRK) channels by GPCRs via 
the G protein β subunits has been well characterized. However, how a non-GIRK channel like 
Kir7.1 is regulated by GPCRs is not understood. We report here that Kir7.1 is regulated by GPCRs 
through a different mechanism. We have previously established that glycosylation is essential for 
Kir7.1 channel function. Using Western blot analysis, we observed that multiple GPCRs tested 
caused a striking reduction in the complex glycosylation of Kir7.1. Further, GPCR-mediated 
reduction of Kir7.1 glycosylation in HEK293T cells did not alter its expression at the cell surface 
but decreased channel activity. The MC4R, a GPCR previously reported to induce ligand-regulated 
activity of this channel, is the only GPCR tested that does not have this effect on Kir7.1. These 
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results indeed reveal a new mode of Kir7.1 channel regulation through GPCR mediated 
suppression of glycosylation. 
 
Introduction 
 
Among inward rectifiers, Kir7.1 is one of the least studied ion channels. While its role in 
regulating potassium homeostasis in the RPE is well understood, its function and regulation in 
other tissues is unclear (Kumar and Pattnaik 2014). Recent studies have identified a role for Kir7.1 
in the regulation of uterine smooth muscle excitability (McCloskey, Rada et al. 2014). Specifically, 
Kir7.1 expression is elevated by 30-fold mid-gestation, hyperpolarizing muscle cells and reducing 
uterine excitability. This expression falls off toward the end of pregnancy, leading to parturition. 
In the mouse, Kir7.1 null mutations cause perinatal lethality, and this was determined to be due to 
a role for Kir7.1 in tracheal tubulogenesis (Yin, Kim et al. 2018). Kir7.1 was also revealed to be a 
potential regulator of neuronal excitability in the paraventricular nucleus of the hypothalamus, 
through modulation of channel activity by the G-protein coupled MC4R (Ghamari-Langroudi, 
Digby et al. 2015). Activation of MC4R led to robust neuronal depolarization, which was found 
to be mediated by Kir7.1 channel closure. Conversely, inhibition of MC4R by an endogenous 
inverse agonist, AgRP, led to channel opening and hyperpolarization of the neuron. These results 
are interesting in that Kir7.1 is not a canonical G-protein coupled inwardly rectifying (GIRK) 
channel such as Kir3.x. Furthermore, in transfected HEK293T cells, Kir7.1 was found to exist in 
a complex with MC4R (Ghamari-Langroudi, Digby et al. 2015).  
Mechanisms by which non-GIRK channels interact with GPCRs vary, with some channels 
behaving like ‘GIRKs’, such as Kir2.x channels. Specifically, unlike Kir2.1, it has been reported 
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that Kir2.3 channels can be inhibited directly by Gβγ complexes (Cohen, Sha et al. 1996). 
Moreover, within dendritic spines of cholinergic neurons, M1 receptor activation has been shown 
to lead to inhibition of Kir2.x channels through Gq activation of phospholipase C (PLC), which 
depletes the second messenger phosphatidylinositol 4,5-bisphosphate (PIP2) that is needed for Kir 
channel function. (Shen, Tian et al. 2007). Kir7.1 likewise has a PIP2 dependence for activity, and 
was recently shown in RPE cells to be regulated by the Gq coupled Oxytocin GPCR, through PLC 
mediated inhibition (York, Halbach et al. 2017). However, the MC4R mediated closure of Kir7.1 
appears to be independent of G-proteins (Ghamari-Langroudi, Digby et al. 2015). The mechanism 
by which this occurs is unknown, but examples exist of accessory proteins regulating Kir channels 
in the absence of G proteins and other second messengers. For example, Kir6.2 and the non-GPCR 
sulphonylurea receptor (SUR), a target of sulphonylurea drugs used to treat diabetes, form the 
KATP channel (Raphemot, Swale et al. 2014). This hetero-octamer composed of Kir6.2 subunits in 
1:1 stoichiometry with SUR1/2 is expressed in the pancreas and ATP binding to the SUR subunits 
increases channel open probability (Aittoniemi, Fotinou et al. 2009). SUR communicates with 
Kir6.2 through direct interaction between the C terminal tail of Kir6.2 and an intracellular loop of 
SUR (Li, Wu et al. 2017, Martin, Yoshioka et al. 2017).  
In our initial investigations of potential molecular mechanisms of interaction between 
Kir7.1 and MC4R, we observed that co-expression of several GPCRs with Kir7.1 in HEK293T 
cells led to a dramatic reduction in complex glycosylated forms of Kir7.1 present in the cell. A 
review of the role of glycosylation within this family of inwardly rectifying potassium channels 
revealed that glycosylation of Kir1.1, a close family member, reduces open channel probability 
(Schwalbe, Wang et al. 1995, Pabon, Chan et al. 2000). We have also previously described, that 
Kir7.1 likewise requires glycosylation for channel function (see Chapter II). In patients with 
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multiple sclerosis, autoantibodies against glycosylated forms of Kir4.1 have been reported but a 
role for this in the pathophysiology of the disease is unclear (Pröbstel, Kuhle et al. 2016, Marnetto, 
Valentino et al. 2017). We report here on a novel functional role of GPCRs in the complex 
glycosylation and function of Kir7.1. 
 
Results 
 
Kir7.1 channel glycosylation is altered by the beta-2-adrenergic receptor (β2AR) 
The alpha-MSH neuropeptide regulates food intake and energy expenditure through the 
MC4R, a G protein-coupled receptor. Studies of MC4R neurons suggested this receptor regulates 
neuronal depolarization and activation by ligand-mediated regulation of the conductance of Kir7.1 
(Ghamari-Langroudi, Digby et al. 2015). Further, these studies supported a G protein-independent 
mechanism of regulation of Kir7.1. To investigate this unusual mode of Kir regulation, we first 
co-expressed a c-terminal flag tagged Kir7.1 with either 3HA-MC4R, or as a control with the 
widely studied beta-2-adrenergic receptor (3HA- β2AR) in HEK293T cells in the absence of 
ligand. We selected the β2AR as a control as this receptor also couples to GS.  Unexpectedly, we 
observed a significant reduction in the 50kDa migrating doublet of Kir7.1 when co-expressed with 
β2AR, whereas MC4R caused a small increase in this form of the channel in some experiments 
(Fig. 3.1A). Treatment of cells with melanocortin agonists, shown to reduce Kir7.1 currents in 
PVN MC4R neurons (Ghamari-Langroudi, Digby et al. 2015), had no effect on the typical amount 
or pattern of Kir7.1 bands observed (not shown). Using endoglycosidases, we previously 
confirmed the upper 50kDa bands as the Endo H resistant mature/complex glycosylated form of 
the channel, indicating that these bands are Kir7.1 that include glycans added in the Golgi complex 
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(Chapter II Fig 2.1). We established a metric for the proportion of Kir7.1 complex glycosylation, 
by determining the ratio of mature/complex glycosylation, to immature core glycosylated plus 
unglycosylated forms of the protein. While some variability in this ratio was seen, a value of 
approximately 1 was typically observed across multiple Kir7.1 expression trials in HEK293T cells 
in the absence of GPCR co-expression. Co-expression with β2AR reduced the ratio of 
glycosylation to less than 0.5, whereas MC4R exhibited a trend towards increasing this ratio, 
indicating opposing effects of these GPCRs (Fig. 3.1B). As differential glycosylation of Kir 
channels have been reported across different tissue subtypes (Hibino, Fujita et al. 2004), we tested 
whether β2AR would likewise mediate a loss of glycosylation in the Cos1 cell line.  The striking 
loss of Kir7.1 glycosylation observed within HEK293T cells when co-expressed with β2AR was 
repeated within Cos1 cells compared to the WT channel, and co-expression with MC4R again 
lacked the same effect (Fig 3.1C-D). This further indicated the strong specificity of the β2AR-
Kir7.1 interaction.  
 
 
 
 
 
 
 
 
 
 
  45 
 
 
Figure. 3.1 Inhibition of complex glycosylation of Kir7.1 by the β2AR.  
A. Western blot analysis from whole cell lysates of transiently transfected HEK293T cells with 
3XFLAG tagged Kir7.1 alone, or co-expressed with either 3HA tagged β2AR or the MC4R. 
Transfections in A and B were performed using 0.25ug of expression vector for the channel and 
the β2AR. 2.5 ug of expression vector for the MC4R was used to achieve receptor expression 
levels comparable to that seen with the β2AR (see Fig. 3.2)  B. Densitometric quantification of 
the blot shown in A, showed that MC4R had a modest increase in the ratio of mature to 
immature forms of kir7.1 p<0.05, whereas β 2AR significantly reduced the ratio of mature forms 
of Kir7.1 p<0.005. C. β 2AR also reduces the ratio of mature to immature glycosylated Kir7.1 in 
Cos1 cells. Western blot analysis of whole cell lysates from Cos1 cells co-expressing Kir7.1-
3XFLAG with either 3HA- β2AR or 3HA-MC4R. D. 3HA- β2AR also reduced Kir7.1 mature 
glycosylation in Cos1 cells as shown in the quantification by densitometric analysis, p<0.05. 
Data analyzed from three-four independent experiments analyzed in Graphpad Prism, with one-
way ANOVA. Error bars for all data represents S.D. 
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Dose-responsive inhibition of Kir7.1 complex glycosylation with increased β2AR expression  
With the striking observation of reduced Kir7.1 glycosylation following β2AR but not 
MC4R co-expression, we were curious whether differences in receptor expression levels could 
account for the proportion of Kir7.1 complex glycosylation observed. To examine this, we co-
expressed Kir7.1 with increasing amounts of either MC4R or β2AR protein and assessed 
glycosylation by western blot analysis. We observed that increasing the amount of MC4R 
expressed had no effect on proportion of Kir7.1 complex glycosylation, whereas increasing 
amounts of β2AR potentiated the loss of complex glycosylation (Fig. 3.2A-B). Moreover, co-
expression with β2AR appeared to be increasing the amounts of core-glycosylated/immature 
Kir7.1 expressed. We determined the change in ratio of Kir7.1 glycosylation with changes in 
receptor expression, and β2AR mediated a progressive reduction in the ratio of complex to 
immature forms (unglycosylated and core glycosylated) of Kir7.1 (Fig. 3.2C). Increases in the 
amount of MC4R protein expressed did not have an effect on the ratio of mature/immature forms 
of Kir7.1. As a control, and to determine whether the effect on glycosylation was specific to Kir7.1, 
we assessed whether overexpression of either GPCR would alter the glycosylation of the widely 
studied vesicular stomatitis virus glycoprotein (VSVG) tagged with GFP. VSVG-GFP is used to 
elucidate protein trafficking, where forms of the protein that have mature/complex glycosylation 
are Endo H resistant. This can be determined by observing a band shift when comparing Endo H 
treated versus untreated cell lysates of VSVG-GFP with either GPCR. We first treated cells 
transiently expressing VSVG-GFP only with a transport inhibitor (BFA/Monesin) to prevent 
complex glycosylation and observed the band shift in comparison to untreated samples as a control 
(Fig. 3.2D). Keeping expression levels of Kir7.1 constant throughout (.25ug of expression vector),  
and varying β2AR expression five-fold (from 0.05 to 0.25ug of expression vector), the high 
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expression levels of β2AR that altered Kir7.1 glycosylation in Fig. 3.1A (0.25ug of expression 
vector), had no effect on the glycosylation of the VSVG-GFP protein (Fig 3.2E, lanes 7-8). Only 
when β2AR was overexpressed 3-fold relative to Kir7.1 (0.25ug of Kir7.1: 0.75 ug of β2AR) was 
VSVG-GFP glycosylation affected, most likely due to squelching of glycosylation machinery. 
With the exception of the overexpression shown in Fig 3.2E, lanes 9-10,  the western blot analyses 
reported here never exceeded the 1:1 transfection of 0.25ug each of Kir7.1 and β2AR expression 
vectors. MC4R also did not alter VSVG-GFP glycosylation at levels used throughout this 
experiment (Fig. 3.2F).  These data further indicated a unique effect of β2AR expression, in 
contrast with MC4R, on suppression of Kir7.1 complex glycosylation, at expression levels that 
have no effect on the glycosylation of VSVG protein.  
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Figure 3.2 Increasing amounts of the β2AR increase the amounts of unglycosylated and core-
glycosylated forms of Kir7.1, while the melanocortin-4 receptor does not.  
A-B HEK293T cells were transiently transfected with a fixed amount of 3xFLAG tagged Kir7.1 
(0.25ug) in the presence of increasing concentrations of 3HA- β2AR (0.05, 0.08, 0.125, 0.25ug) 
or 3HA-MC4R plasmid DNA (0.5, 0.8, 1.25, 2.5ug). Whole cell lysates were analyzed by 
western blot analysis. To assess receptor expression levels, samples were rerun on a separate 
blot, and imaged with anti HA. This blot was stripped and reprobed for the loading control 
GAPDH to confirm plasmid concentration based increase in receptor protein levels. C. 
Densitometric analysis of the anti-FLAG blot to determine the ratio of mature to complex 
glycosylation.  Densitometric analysis was also performed on the receptor blot, and normalized 
to the GAPDH loading control for both β2AR expression and MC4R expression. The ratio of 
mature to immature Kir7.1 glycosylation was plot against Log2 receptor intensity values, and a 
linear regression line fitted to the data points. Data representative of at-least 3 experiments. D-F. 
  49 
 
Comparable increases in receptor expression do not alter VSVG protein glycosylation. Whole 
cell HEK293T lysates transiently expressing VSVG-GFP (0.25ug) with Kir7.1 (0.25ug) or 
increasing concentrations of β2AR (0.08, 0.125, 0.25ug) or MC4R (0.8, 1.25, 2.5ug), were 
treated +/- Endo H.  As a control, VSVG-GFP only expressing cells were treated with a transport 
inhibitor (BFA-Monesin) and compared to untreated cell lysate. Anti HA Blots show receptor 
expression levels. (**) Endo H resistant, (***) Endo H sensitive.  VSVG-GFP+3HA-β2AR OE 
wells show that a 3-fold overexpression of β2AR (0.75ug) can affect VSVG-GFP glycosylation. 
Data representative of three independent experiments. 
 
 
β2AR reduced Kir7.1 mediated whole cell currents 
Given the specific effect of β2AR on Kir7.1 glycosylation, we investigated whether this 
had an effect on the function of Kir7.1. To study the functional effect of the β2AR mediated loss 
of Kir7.1 complex glycosylation, Kir7.1 whole-cell recordings were performed in the absence of 
any ligand in transfected HEK293T cells. Whole-cell patch clamp recordings were performed 
following Kir7.1 transfection, and over-expression of either β2AR or MC4R. Since the Kir7.1 
wild-type (WT) channel was found to have a small unitary conductance (Doring, Derst et al. 1998), 
we used a mutant form of the channel in which the methionine within the pore was replaced with 
an arginine typically found in the pore of other two-transmembrane domain Kir channels (Kir7.1-
M125R). This mutant has been widely validated and used in multiple studies of Kir7.1 activity 
(Doring, Derst et al. 1998, Lewis, Bhave et al. 2009, Raphemot, Lonergan et al. 2011). Kir7.1-
M125R expressed alone compared to co-expression with MC4R yielded no differences in whole-
cell current, which aligned with previous observations (Ghamari-Langroudi, Digby et al. 2015) 
(Fig. 3.3A-B). However, β2AR caused a >50% reduction in Kir7.1 whole cell mediated currents 
(Fig. 3.3C-D). As Kir7.1-M125R channels exhibit barium sensitivity, activity of expressed Kir7.1 
was taken as the total amount of current inhibited by barium at the end of the experiment. In 
general, reduced responses to changes in voltage were observed when Kir7.1 was co-expressed 
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with β2AR (Fig 3.3D). As these experiments were performed in the absence of ligand, this 
suggested either glycosylation reduces the amount of functional channel at the surface of the cell, 
or directly alters channel function. We previously established that glycosylation is required for 
channel function (Chapter II), where the absence of glycosylation leads to a reduction in channel 
open probability. We wanted to further confirm that the reduced function observed was due to 
altered glycosylation and not β2AR. We co-expressed β2AR with our previously profiled 
glycosylation resistant mutant Kir7.1 M125R N95Q (Chapter II Fig. 3.3) to see if the receptor 
mediated any further reduction in channel activity. Current densities recorded at a test pulse of -
180 mV were no different for Kir7.1-M125R-N95Q alone (110.8 ± 31.7 pA/pF) or Kir7.1-M125R-
N95Q co-expressed with β2AR (107.4 ± 21.8 pA/pF, p = 0.8857, unpaired t test) (Fig 3.4). These 
findings support our conclusion that β2AR modulates Kir7.1 channel function by inhibiting 
complex glycosylation.  
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Figure 3.3 Coexpression of the β2AR reduces total Kir7.1 mediated whole cell currents.   
A. Whole cell patch clamp recordings from HEK293T cells transiently expressing Kir7.1-M125R 
only, versus Kir7.1-M125R co-expressed with MC4R (N=5). A representative current-voltage (I-
V) relationship is shown in B. The Kir7.1-M125R mutant has a methionine in the pore of the 
channel mutated to an arginine typically found at the same site in most other Kir channels. This 
mutation significantly increases the amount of detectable currents from the channel, with increased 
sensitivity to barium. Therefore, the amount of current inhibited by barium at the end of the 
experiment, was recorded as the total current of Kir7.1-M125R from HEK293T cells. Mock 
transfected cells did not exhibit barium sensitive currents (data not shown). C. Kir7.1-M125R co-
expressed with β2AR showed a significant reduction in whole cell current in pA/pF, p0.0001 (N=7 
cells), error bars represent S.E.M. D. Representative current- voltage (I-V) relationship of Kir7.1-
M125R (●) in the presence or absence of β2AR (●). Experiment performed by Daniel Swale 
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Figure 3.4 Co-expression with the β2AR did not change Kir7.1-M125R-N95Q mediated whole 
cell currents. 
A. Representative whole cell patch-clamp recordings from HEK293T cells transfected with 
Kir7.1-M125R-N95Q and Kir7.1-M125R-N95Q co-expressed with β2AR. Cells were held at 
−60 mV and voltage steps were applied from −180 to 0 mV in 10 mV increments. B. The current 
density versus test potential (I–V) relationship for Kir7.1-M125R-N95Q and Kir7.1-M125R-
N95Q co-expressed with β2AR. Error bars on each symbol represent the mean ± S.D (N = 
3).  Experiment performed by Ciria C. Hernandez 
 
 
β2AR mediated loss of complex glycosylation does not alter total Kir7.1 surface expression 
We next investigated whether co-expression with β2AR altered the amount of Kir7.1 
trafficked to the cell surface. Cells co-expressing β2AR or MC4R with Kir7.1 were biotin labeled, 
and assessed for cell surface expression by western blot analysis. This method allowed 
visualization of the different glycosylated forms of Kir7.1 reaching the cell surface. Surprisingly, 
Kir7.1 co-expression with β2AR and loss of complex glycosylation did not cause a reduction in 
the percentage of Kir7.1 protein on the cell surface (Fig. 3.5B). MC4R likewise had no effect on 
Kir7.1 surface expression. Additionally, we assessed whether the ratio of complex to immature 
forms of Kir7.1 at the surface changed in the presence of these GPCRs (Fig. 3.5C). This remained 
unchanged, with β2AR maintaining a <0.5 ratio of complex Kir7.1 glycosylation compared with 
the total glycosylated Kir7.1 expressed in the cell. A slight reduction in the ratio of surface 
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mature/immature Kir7.1 following MC4R expression was observed, but this trend was not 
significant over multiple experiments. These results therefore indicate that complex glycosylation 
is not required for surface expression of Kir7.1. 
 
 
 
Figure 3.5 Co-expression of the β2AR does not reduce the total amount of Kir7.1 at the plasma 
membrane, but alters the ratio of mature glycosylated forms of Kir7.1 at the surface.  
Transfection levels were as in Fig. 3.1. A. Western blot analysis of surface biotinylation of cells 
transiently transfected with 3xFLAG tagged Kir7.1 co-expressed with the 3HA- β2AR or 3HA-
MC4R. The experiment was performed as described in Chandrasekhar et al 2006(Chandrasekhar, 
Bas et al. 2006). Cells were labeled with Sulfo-NHS-SS-Biotin, and surface proteins were 
immunoprecipitated with streptavidin agarose beads. At least 45ug of pre-quantified total protein 
was immunoprecipitated and loaded per lane. 15ug (1/5) of total input protein was loaded for 
comparison. B. GAPDH control, indicated that cells remained intact throughout biotinylation. 
Surface quantification was determined by densitometry analysis of the mature/complex doublet, 
versus immature. Percent surface biotinylation was determined by dividing the values in the 
surface lanes by the input lane values multiplied by five. Percentages of complex or immature 
Kir7.1 at the surface were compared.  See methods for data exclusion criteria.The error bars 
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represent S.D, with no significance observed between conditions determined by one-way 
ANOVA. C. Comparison of the ratio of mature to immature forms of Kir7.1 in whole cell lysates 
versus cell surface biotinylated proteins. Representative of 3-5 independent experiments, p<0.05; 
p<0.005, error bars represent S.D. 
 
 
Other beta-adrenergic receptors also alter Kir7.1 glycosylation 
 We next sought to determine if suppression of complex glycosylation and function of 
Kir7.1 was unique to the β2AR. For this, we first tested whether the β1 and β3 adrenergic receptors 
also mediated alterations in Kir7.1 glycosylation. We saw a similar reduction in the proportion of 
complex glycosylation when co-expressing these other beta-adrenergic receptors with Kir7.1 in 
HEK293T cells (Fig. 3.6A). Special care was taken to express the receptors at similar levels to 
allow adequate comparison for changes in glycosylation. β1AR and β3AR similarly reduced the 
ratio of Kir7.1 glycosylation as seen with β2AR, with β1AR having a slightly lower value (Fig. 
3.6B). This however may be due to receptor expression of β1AR being slightly higher than β2AR 
(Fig. 3.6A). These results indicate that our original observation was not specific to the β2AR 
receptor but shared by others GPCRs tested within the family. We also attempted to screen a larger 
panel of GPCRs for effects on glycosylation (MC1R, MC3R, OTXR), and did indeed see a 
reduction in Kir7.1 glycosylation ratio (Fig 3.7). While we were unable to attain consistent receptor 
expression levels for these receptors, the results suggest that many GPCRs suppress the complex 
glycosylation of Kir7.1   
 
 
 
 
  55 
 
 
Figure 3.6 Multiple GPCRs inhibit Kir7.1 glycosylation. A. Western blot analysis of HEK293T 
whole cell lysates transiently transfected with 3xFLAG tagged Kir7.1, co-expressed with 
different 3xHA tagged beta-adrenergic receptors in the absence of ligands. Transfection levels 
were as in Fig. 3.1. Receptor expression was analyzed on a separate blot, with the loading control 
GAPDH shown. B. Densitometric analysis of the anti FLAG immunoblot of Kir7.1 shown in A, 
to quantify the ratio of mature to immature glycosylation p<0.005. Data from 3 independent 
experiments were analyzed by one-way ANOVA in Graphpad Prism, with Tukey posttest for 
multiple comparisons with S.D. 
 
 
 
Figure 3.7 Other GPCRs alter Kir7.1 glycosylation to varying degrees. 
In a screen for the effect of other GPCRs on Kir7.1 complex glycosylation, cells were transiently 
transfected with Kir7.1-3xFLAG and various 3HA tagged GPCRs. 24 hours post transfection, 
samples were analyzed by western blot analysis. Receptor expression levels were not controlled 
in this experiment, and the ratio of Kir7.1 glycosylation was determined from two independent 
experiments. Bars indicate the mean ratio. 
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Β2AR forms complexes with Kir7.1 
 With β2AR suppressing Kir7.1 complex glycosylation and not altering surface 
expression, we wanted to determine how the receptor might mediate its effects on Kir7.1. In 
chapter II, we established that Kir7.1 requires the Golgi export patch residues SY for complex 
glycosylation to occur. Thus, we wondered how these receptors may potentially block 
glycosylation from occurring in the Golgi. MC4R is the only GPCR tested that does not suppress 
Kir7.1 glycosylation, but has been shown to form complexes with the channel in HEK293T cells 
(Fig 3.8B) (Ghamari-Langroudi, Digby et al. 2015). Likewise, we co-expressed Kir7.1 with β2AR 
and co-immunoprecipitated (co-IP) complexes of the two proteins in HEK293T cells (Fig 3.8A). 
Interestingly, β2AR co-IP’d with only the immature form of the channels though small amounts 
of complex glycosylated forms were present in the cell. This suggest that the two proteins most 
likely need to be in contact for GPCR mediated suppression of complex glycosylation. 
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Figure 3.8 Kir7.1 co-immunoprecipitates with the β2AR. 
A. Cells transiently transfected with Kir7.1-3xFLAG and 3HA-β2AR, were cross-linked with 
DSP prior to cell lysis. Anti-Flag M2 antibody or Anti HA antibody was used to 
immunoprecipitate the protein complex before analysis by western blot. Anti-Flag M2 antibody 
immunoprecipitated all forms of Kir7.1 expressed in the cell, which appears identical to the input 
lane. However, IP with the anti HA antibody to capture the β2AR, only co-immunoprecipitated 
the immature forms of Kir7.1. Data representative of three independent experiments. Detailed IP 
protocol outlined in methods. B. Image from (Ghamari-Langroudi, Digby et al. 2015). Cells 
transfected with Kir7.1-3xFLAG and 3HA-MC4R, were reversibly crosslinked with 
dithiobismaleimidoethane (DTME), and cells lysates were IP’d prior to western blot analysis. 
Blots shows that all forms of Kir7.1 co-IP with MC4R in HEK293T cells. F- Flag M2 antibody, 
HA- Anti HA antibody, X- no antibody control. Reproduced from Ghamari-Langroudi, Digby et 
al. 2015 with permission. 
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Discussion 
 
G protein inwardly rectifying potassium channels (GIRKs) are Kir family members best 
understood to be regulated by GPCR signaling (Hibino, Inanobe et al. 2010, Luscher and Slesinger 
2010).  Our study reveals another mechanism by which GPCRs appear to regulate the function of 
another inward rectifier, Kir7.1, prior to cell surface expression. Our results demonstrate a highly 
specific effect of GPCRs on Kir7.1 glycosylation, which in turn directly regulates channel 
function. Specifically, we have shown that a reduction in the proportion of channel subunits 
undergoing complex glycosylation is mediated by expression of a wide variety of GPCRs. Further, 
we observed that the reduction in Kir7.1 whole cell currents when co-expressed with unliganded 
β2AR (Fig. 3.3, Fig. 3.6) was indeed due to loss of complex glycans, an event occurring prior to 
trafficking of the channel to the cell surface. The MC4R has previously been reported to regulate 
Kir7.1, with agonists inhibiting and antagonists stimulating channel function, however expression 
of the MC4R did not reduce complex glycosylation of the channel, with or without the presence 
of ligand.  Nonetheless, it is intriguing to note that the MC4R is one of the few GPCRs we 
examined that leaves channel glycosylation intact. 
Of other non GIRK channels that interact with GPCRs, Kir4.1 is reported to interact with 
the calcium sensing receptor (CaR) GPCR within the kidney (Cha, Huang et al. 2011). Co-
expression of CaR and Kir4.1 in HEK293 cells was found to reduce surface expression of the 
channel thereby limiting its activity. This was also reported to hold true for Kir4.2 and was found 
to be mediated by CaR Gq signaling and internalization by caveolin-1(Huang, Sindic et al. 2007, 
Cha, Huang et al. 2011). This was not the case with β2AR’s effect on Kir7.1 wherein co-expression 
with β2AR did not reduce Kir7.1 surface expression. In the case of CaR and Kir4.1, it was indeed 
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reported that mutant non-functional CaRs were unable to have an effect on Kir4.1 surface 
expression or activity (Huang, Sindic et al. 2007). We have not yet tested what function(s) of 
GPCRs are needed to alter glycosylation of Kir7.1.  
While glycosylation is indeed not required for surface expression of ion channels such as 
Kir2.1 which is seemingly unglycosylated, we were surprised to see expression of immature forms 
of Kir7.1 at the cell surface. Particularly, the use of cell surface biotinylation allowed us to profile 
the different forms of the channel present at the surface and obtain a ratio of complex to immature 
plus unglycosylated forms. In co-expression with β2AR, the ratio of complex glycosylation 
remained unchanged at the surface, indicating that GPCR expression, and inhibition of complex 
glycosylation, does not associate with altered trafficking of the channel. Furthermore, we have 
previously shown that these channels can exist as heterotetramers of unglycosylated, partially 
glycosylated, and fully glycosylated subunits (Chapter II Fig 2.5). Therefore, a change in the ratio 
of glycosylation most likely reflects a change in channel subunit composition.  This would thereby 
contribute to subunit “poisoning” of Kir7.1 tetramers further influencing the reduction in channel 
activity observed (Fig 3.3C-D). We also observed complexes of β2AR with the immature forms 
of Kir7.1 by co-immunoprecipitation (co-IP) in cells (Fig 3.8). After crosslinking, only the 
immature forms of Kir7.1 co-IP’d with β2AR, though small amounts of complex Kir7.1 were 
present in the cell as observed in the input lane. This suggests that immature channels may be the 
predominant form in the cells when co-expressed with certain GPCRs. 
Since β2AR forms complexes with the immature form of the channel, this suggests a 
possible mechanism for the GPCR mediated loss of glycosylation. The protein titration experiment 
showed a progressive increase in immature forms of the protein, with increased expression of 
β2AR. The amount of complex glycosylated Kir7.1 however was generally reduced. A possible 
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hypothesis is that β2AR forms complexes with Kir7.1 early in the endoplasmic reticulum, and 
sterically blocks Kir complex glycosylation in the Golgi. Alternatively, the β2AR could also 
differentially stabilize immature forms of the protein. The potential role of G proteins in the 
formation of these proposed receptor-channel complexes should be examined in future 
experiments. 
The AP-1 gamma adaptin protein is the only protein reported in literature to bind to the 
Golgi export site in Kir channels. The role of this protein in glycosylation has not been 
investigated, or any other proteins that may bind to this site to mediate complex glycosylation. Our 
data suggest that GPCRs such as β2AR are indeed preventing this crucial step of glycosylation 
from occurring, though the mechanism is unclear. It is plausible that GPCRs may indeed be 
blocking proteins from binding to this protein export site which we have shown is required for 
glycosylation. 
Both the oxytocin receptor (York, Halbach et al. 2017), and the MC4R (Ghamari-
Langroudi, Digby et al. 2015) have been shown to regulate Kir7.1 function at the membrane in a 
physiologically relevant manner, with the former mediated via a PIP2 intermediate.  The 
mechanism(s) for regulation of Kir7.1 by MC4R remain to be determined, although the potential 
for Kir7.1 and MC4R to form complexes was shown by co-IP of tagged proteins from HEK293T 
cells (Ghamari-Langroudi, Digby et al. 2015). The inability of the MC4R to block complex 
glycosylation of Kir7.1, relative to other GPCRs we tested, is not understood, although it has been 
noted that the MC4R is one of the smallest GPCRs. One hypothesis is that MC4R may only form 
complexes with Kir7.1 post Golgi export, but this has not been tested. To study this, careful 
detection methods should be employed such as fractionation of membrane compartments followed 
by co-IP, or using super resolution microscopy combined with fluorescent tag protein 
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complementation. 
The data shown here provide evidence for molecular regulation of Kir7.1 structure and 
function by GPCRs. Within tissues where Kir7.1 is highly expressed, large variations in 
glycosylation have been recently observed using a knock-in mouse expressing an HA tagged 
Kir7.1 channel (Cornejo, Villanueva et al. 2018). Notably, the study showed predominantly 
immature forms of the channel in the lung, a tissue with high levels of ß-adrenergic receptor 
expression, whereas full complex glycosylation was observed in the trachea (Cornejo, Villanueva 
et al. 2018). No explanation for variation in glycosylation patterns between these two tissues was 
given, but our data may suggest a possible mechanism by which such changes could occur.  
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CHAPTER IV 
 
Conclusions and Future Directions 
 
  
Probing the mechanism of glycosylation on channel function 
 In chapter II, we showed that glycosylation of Kir7.1 is essential for channel function. 
Specifically, the Kir7.1 N95Q mutant had a 40% reduction in channel amplitude versus wildtype, 
as well as a 50% reduction in open channel probability. These experiments were performed by 
single channel recordings and thus reflect the function of individual channels on the membrane of 
the cell. The glycosylation site N95Q was found by homology model analysis to be located in the 
extracellular loop within the turret region. In the Kir2.2 crystal structure the turret region is highly 
structured on the extracellular surface of the channel suggestive of a particular role in function 
(Fig. 4.1)(Tao, Avalos et al. 2009). The authors of that study postulate that turrets seem to 
“surround” and “protect” the pore gateway. Whether this is true has not been tested. The Kir7.1 
homology model was built based on the Kir2.2 crystal structure. The turret region of Kir7.1 is not 
only two residues longer than Kir2.2, but it also contains two proline residues in succession which 
could potentially change the direction in which the loops point. The only Kir channel with a longer 
turret region than Kir7.1 is Kir6.1/6.2 (Fig. 4.1).  
One method to probe the mechanism of glycosylation is by modeling the different 
conformations of Kir7.1 with the prolines as shown in figure 4.1. Next, site directed mutagenesis 
should be employed to determine whether changing the prolines to similar residues found in 
Kir2.2, would cause a loss of glycosylation or have some other impact on function. Additionally, 
whether these mutations affect channel assembly should also be explored. It is postulated that these 
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loops may either point towards the pore as shown in Kir 2.2, or the prolines induce a turn away 
from the pore (Fig. 4.1E). In the first scenario, the glycans which are large structures adding over 
15Kd to the protein size as observed by western blot would tower over the pore. In the transient 
receptor potential 8 ion channel (TRPM8) which is activated by cold temperature, the presence of 
N-glycans in extracellular loops around the pore modulate the channel’s responsiveness to 
temperature change (Pertusa, Madrid et al. 2012). Glycosylation may likewise have this effect on 
gating in Kir7.1. Alternatively, if the glycans point away from the pore, they will point to the 
abutting subunit in the tetramer, possibly linking the ion tetramer together to form a functional 
channel. Studying assembly of the Kir channel in non-denaturing conditions by western blot 
analysis would begin to answer this question, coupled with structure analysis of Kir7.1. This could 
be done by expressing either the WT or mutant channel in HEK293T cells, and analyzing whole 
cell lysates on a non-denaturing gel. If the absence of glycans reduces tetramer formation, a 
reduced number of  high kDA running bands would be observed. This experiment may however 
be challenging to perform, due to membrane proteins forming aggregates that may not run cleaning 
through the gel in the absence of denaturing conditions. No published structures of Kir7.1 currently 
exist. However, preliminary evidence suggest that the N95Q mutant assembles properly as it co-
immunoprecipitates with the WT channel, and with SY mutant subunits which do not have 
complex glycosylation (Chapter II Fig 2.5). The experiments outlined above would shed light on 
the exact mechanism. 
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Figure 4.1 Glycosylation site of Kir7.1 is in the turret region and gates the pore. 
A. Sequence comparison of turret regions within Kir channels. The proline residues present in 
Kir7.1 are shown in the red box. Image adapted from Tao et al 2009. B. Structural comparison of 
the turret region of Kir2.2 crystal shown in blue, and the homology model of Kir7.1 shown in 
green. The proline regions are highlighted in orange and the asparagine side chain glycosylation 
site is shown in red. C. Surface homology model of Kir7.1 looking downward into the pore. The 
red regions highlighted are the glycosylation sites gating the pore. D and E, representation of the 
potential turret loop confirmations of Kir7.1. Loops may point towards the pore A, or away from 
the pore. Glycans are shown in red. Model of Kir7.1 created using SWISS-MODEL based on 
homology to Kir 2.2, and refined with PyMOL (see methods for structural models and protein 
alignments in Chapter V). 
 
 
Retinopathy associated mutations in Kir7.1 that affect glycosylation 
 We discovered that a mutation in other parts of Kir7.1 outside of the glycosylation site 
can affect the ability of glycans to be added to the protein (See Fig. 2.6 in Chapter II). We found 
that the L241P Leber congenital amaurosis (LCA) associated mutation in Kir7.1 leads to a 
reduction in protein expression and a loss of complex glycosylation. We did not notice this 
pattern in other mutations tested, but our list was not exhaustive. Indeed, other mutations in 
Kir7.1 have been identified that are associated with retinopathies that should be assessed (see 
table 1). The location of the L241P mutation is in the C terminal region of the protein (Fig 4.2), 
and literature suggest that this may affect appropriate protein folding (Sergouniotis, Davidson et 
al. 2011). Whether the glycosylation site remains accessible in this protein is unknown.  
Additionally, whether these mutations affect the ability of the protein to form stable tetramers 
may also provide a reason for loss of function. On a molecular level, most of these mutations 
have not been studied in detail. Given that this dissertation describes the ability of GPCRs to 
differentially alter the glycosylation of the channel, would any of these mutations affect this 
interaction? While the exact mechanism of Kir7.1-GPCR protein-protein interaction remains 
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unknown, these mutations may provide a clue into the structure function relationship of the 
channel. 
Table 4.1 Sequence variants of Kir7.1 found within the human genome of individuals with 
diagnosed LCA 
Nucleotide Amino 
Acid 
Prediction Effect on 
Glycosylation 
Reference 
208G>T Val70Phe No effect Not tested (Sergouniotis, Davidson et 
al. 2011) 
214G>T Ala72Ser Possible loss of 
function 
Not tested (Sergouniotis, Davidson et 
al. 2011) 
344A>G Glu115Gly Possible loss of 
function 
Not tested (Sergouniotis, Davidson et 
al. 2011) 
350A>G Gln117Arg Possible loss of 
function 
No (Sergouniotis, Davidson et 
al. 2011) 
484C>T Arg162Trp Non-selective ion 
channel/Loss of 
function 
 
No 
(Hejtmancik, Jiao et al. 
2008) 
485G>A Arg162Gln  
Possible loss of 
function 
 
No 
(Sergouniotis, Davidson et 
al. 2011) 
496C>T Arg166X Early stop codon  (Sergouniotis, Davidson et 
al. 2011) 
722T>C Leu241Pro Possible loss of 
function 
Yes (Sergouniotis, Davidson et 
al. 2011) 
827A>C Glu276Ala Possible loss of 
function 
Not tested (Sergouniotis, Davidson et 
al. 2011) 
925G>T Gly309Cys Possible loss of 
function 
Not tested (Sergouniotis, Davidson et 
al. 2011) 
295G>A W53X Truncated protein  NA (Pattnaik, Shahi et al. 
2015) 
NA - Only first 52 amino acids expressed before stop codon.  
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Figure 4.2 Homology model showing sequence variants of Kir7.1 found in the human genome 
Individual subunit model of Kir7.1, with location of sequence variants shown in magenta with 
amino acid side chain.  Amino acid number and variant change are labelled. Inset image shows a 
surface homology model of an entire Kir7.1 tetramer. The location of the individual subunit 
depicted with variants is shown within the tetramer. Model of Kir7.1 created using SWISS-
MODEL based on homology to Kir 2.2 (see methods for structural models and protein 
alignments). 
 
 
Determining the surface interface of GPCRs and Kir7.1 
 Kir7.1 interacts with and forms complexes with GPCRs as described in chapter III. The 
mechanism and sites of interaction remain unknown. Firstly, it must be determined whether other 
proteins exist in the complex with Kir7.1 and either B2AR and MC4R. This can be studied by 
isolating the complex after transfection and performing mass spectroscopy. For example, mass 
spectroscopy using “MudPIT” (Multi-dimensional Protein Identification Technology) analysis 
would be an initial method to catch all proteins that bind to Kir7.1 after crosslinking and 
immunoprecipitation. Next, individual proteins can be co-expressed with Kir7.1 to confirm 
whether an association exist with or without crosslinking to determine the strength of the 
interaction. However, given that GPCRs recruit proteins when activated, crosslinking may 
stabilize transiently interacting proteins. The presence of AKAPs or other scaffolding proteins 
should be ruled out before these detailed experiments are performed. AKAPs should readily be 
detected in the mass spectroscopy experiment. 
 Surface interface mapping is an emerging technique to allow the detection of direct 
molecular interactions between amino acids in proteins (Rappsilber 2011, Bullock, Sen et al. 
2018). Briefly, this technique utilizes chemical crosslinkers that form irreversible linkages between 
amino acids. A cross linker can be selected to target either primary amines, cysteines or carboxylic 
acids. Once the intact proteins are crosslinked, they undergo trypsin digestion followed by liquid 
  69 
 
chromatography and mass spectroscopy (LC-MS). Mass spectroscopy will detect the free un-
crosslinked fragments in addition to the crosslinked peptides. The peptides are then identified 
against a protein database to detail a list of linked and or free fragments. Using either a crystal 
structure or homology model of both proteins, the interacting peptides can then be identified. To 
confirm the surface interface regions, mutational analysis would then be performed to determine 
if changing specific amino acids or domains on the protein would affect protein complex 
formation. These efforts are currently underway by a collaborator, Dr. Glenn Millhauser, to 
determine the surface interface of Kir7.1 and MC4R. These experiments and others would be 
greatly improved if structures for Kir7.1 and MC4R are resolved. As the B2AR receptor was one 
of the first GPCRs crystalized, it could serve as a starting point to probe the Kir7.1/GPCR protein-
protein interaction (Rasmussen, Choi et al. 2007). 
 While no current structures of Kir7.1 have been published, structures of other family Kirs 
are available- KirBac 1.1, Kir2.2, Kir3.1, Kir6.2 (Nishida, Cadene et al. 2007, Clarke, Caputo et 
al. 2010, Lee, Ren et al. 2016, Li, Wu et al. 2017). None of these sequences are currently of human 
Kirs, but are of highly conserved sequences from other genomes.  Membrane proteins are 
notoriously difficult to obtain crystals for structural determination, but other methods such as 
Cryo-EM have provided simpler alternatives for this work. Dr. Alys Peisley in the Cone laboratory 
has purified Kir7.1 from insect cells, and is currently determining its structure using Cryo-EM. 
Ultimately, the lab hopes to move on to determine a Kir7.1-GPCR structure. 
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Possible mechanisms of GPCR mediated inhibition of Kir7.1 complex glycosylation 
 While MC4R did not alter the complex glycosylation of Kir7.1, all other GPCRs tested 
affected channel complex glycosylation. The mechanism by which this inhibition occurs currently 
remains unclear. Proteins typically traffic through the secretory pathway from the endoplasmic 
reticulum to the Golgi complex before vesicle packaging and relocation to various subcellular 
compartments. Membrane proteins are exported and inserted into the membrane. Immature 
glycosylation occurs in the ER, and complex glycans are added in the Golgi. In the case of GPCRs 
blocking complex glycosylation of Kir7.1, addition of complex glycans is either being blocked at 
a specific point in the Golgi, or could result from the proteins undergoing a Golgi bypass 
mechanism.   
 Some proteins have been shown to traffic to the membrane via an unconventional route 
known as Golgi-bypass. In this case, proteins are packaged in vesicles at the ER, and are routed 
directly to the membrane. This pathway is typically induced in episodes of cellular stress in cells 
where it has been studied (Piao, Kim et al. 2017, Kim, Gee et al. 2018). For example, in epithelial 
Madin-Darbt canine kidney (MDCK) cells, proteins avoided the Golgi and trafficked to the 
membrane in the presence of BFA (Tveit, Akslen et al. 2009). BFA inhibits transport of proteins 
to Golgi, and at high concentrations will result in Golgi complex collapse. Addition of an ER 
retrieval signal peptide to trap cargo in the ER also resulted in Golgi bypass and expression at the 
membrane in untreated cells. In fact, ER stress mechanisms such as the unfolded protein response 
have been also been shown to be involved in this pathway. We tested whether expression of Kir7.1 
and GPCRs induced ER stress by looking for the expression of ER stress markers XBP1s and cell 
death marker Chop (Fig. 4.3). ER stress marker expression levels were not greater when GPCRs 
were expressed with Kir7.1 versus Kir7.1 expressed alone. Additionally, VSVG-GFP, a widely 
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studied glycoprotein was still fully glycosylated when co-expressed in states where GPCRs 
affected Kir7.1 glycosylation (Chapter II, Fig 2.1). This indicated that the Golgi bypass pathway 
was most likely not being induced, and that another mechanism was responsible for the loss in 
glycosylation. 
 
 
 
Figure 4.3 Co-expression of Kir7.1 and GPCRs does not lead to ER stress in induction above 
Kir7.1 expressed alone 
Western blot analysis of cells expressing Kir7.1 alone or co-expressed with B2AR or MC4R for 
the expression of ER stress markers. Mock transfected cells were treated with the transport 
inhibitor BFA/Monesin to induce ER stress, and western blot analysis was performed for the ER 
stress markers XBP1s (Xbox binding protein 1 spliced isoform) or CHOP (C/EBP-homologous 
protein). Data representative of three independent experiments. 
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Complex glycans are added as proteins traffic through different regions of the Golgi 
complex. Membrane proteins are classically thought to traffic progressively through each Golgi 
compartment before transport to the cell surface (cis-medial-trans Golgi network). The point at 
which major complex glycans are added is unclear for ion channels. Endo H resistance is conferred 
with the addition of an N-acetylglucosamine sugar to the mannose-oligosaccharide added in the 
ER (Grieve and Rabouille 2011). The point at which this occurs for different proteins also remains 
unknown. A recent study of the Golgi export site in the Kir2.1 channel was suggestive that this 
addition occurs between the cis and trans Golgi compartments. As described in Chapter II, Kir 
channels share a Golgi export site in which the serine and tyrosine (SY) residues in some channels 
are key for surface expression (Ma, Taneja et al. 2011, Li, Ortega et al. 2016). Deletion of these 
residues trap the channels in the cis and trans Golgi compartments. Researchers found that 
placement of an artificial N-linked glycosylation site in the Kir2.1 Golgi export mutant resulted in 
a protein with core glycans, but lacked complex glycosylation. This suggest complex Endo H 
resistant glycans are added later in these compartments before export to the membrane. Kir7.1 
shares Golgi export patch residues (Chapter II, Fig 2.4), the SY mutant similarly lacks complex 
glycosylation. Our preliminary data suggest that this mutant is not trapped in the Golgi but is 
indeed trafficked to the surface (not shown). The key question to be answered is whether GPCRs 
interact with Kir7.1 in the ER or at this point in the Golgi, and block the access of enzymes to 
allow complex glycosylation. 
 This can be tested through multiple experiments, but currently there are alternate 
hypotheses to how proteins transit through and are exported from the Golgi. In addition to 
progressive trafficking through the Golgi network, another plausible hypothesis is the “ rapid 
partitioning in a mixed Golgi” model (Patterson, Hirschberg et al. 2008, Lippincott-Schwartz and 
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Phair 2010, Glick and Luini 2011). Simply, as shown in Figure 4.4 this hypothesis posits that 
proteins trafficking to the Golgi can partition into one of the Golgi stacks (cis, medial or trans) and 
instead of forward progression through the entire Golgi complex, exit and traffic to the membrane 
from the stack of partitioning, i.e. proteins can be exported directly to the membrane from cis, 
medial or trans stacks . This hypothesis was tested by Patterson et 2008, when they studied the 
kinetics of VSVG-GFP exit from the Golgi in pulse chase experiments. Classical Golgi transport 
suggest a lag in progression time as proteins move through the entire stack before exit. However, 
after a 5 minute pulse labeled proteins were observed leaving the Golgi exponentially with no lag 
observed. Additionally, they observed VSVG-GFP proteins scattered throughout the Golgi by gold 
particle labelling, with no enrichment in the most trans lying stack that would classically serve as 
the export stack. The authors ultimately put forward the hypothesis that VSVG can exit at any 
point in the Golgi complex. 
 As it relates to Kir7.1 and GPCRs, it is possible that GPCRs may prevent complex 
glycosylation by promoting an early Golgi exit before reaching later stacks where complex 
glycosylation occurs. This can be tested using pulse chase experiments and super resolution 
microscopy of trafficking in the Golgi. Using fluorescently tagged proteins, complexes of 
Kir7.1/ß2AR or Kir7.1/MC4R could be tracked actively leaving different Golgi compartments. 
Additionally, membrane organelles can be isolated by differential centrifugation to determine 
where Kir7.1 and GPCRs exist as a complex, as well as changes in Kir7.1 glycosylation states as 
it traffics through the secretory pathway. While there are reports that MC4R is complex 
glycosylated, this was not observed in our experiments, nor does ß2AR itself have complex 
glycosylation (Figure 4.5). Indeed, the alternate Golgi hypothesis may be plausible as these GPCRs 
do not compete for glycosylation enzymes. 
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 While we did no observe complex receptor glycosylation, the presence of glycans on 
ß2AR is reported to play a role in receptor dimerization (Li, Zhou et al. 2017). ß2AR has three N-
glycosylation sites, with N6, and N15 identified as the key residues playing a role in 
homodimerization of the receptor. In fact,  mutation of two residues at the dimer surface interface 
on ß2AR mimicked the glycosylation mutant reduction in dimerization. The interface between 
Kir7.1 and ß2AR or MC4R has not been identified, but a role for receptor glycosylation in the 
interaction remains unexplored. This could be tested by determining whether glycosylation 
mutants of B2AR are still able to inhibit the complex glycosylation of Kir7.1. Additionally, the 
dimer surface interface residues of ß2AR were found to form a salt bridge between the two 
receptors (Li, Zhou et al. 2017). If a ß2AR protein with these mutations is unable to alter channel 
glycosylation, this would indeed indicate a possible receptor interface that facilitates this 
interaction. 
 The stoichiometry of receptor dimerization and complex formation with Kir7.1 also 
remains unexplored. It is unknown whether receptors assemble 1:1 with Kir subunits i.e, one Kir 
tetramer would have 4 receptors bound, or whether a receptor dimer assembles with one Kir 
tetramer. Cryo-EM experiments would provide visual proof of Kir/receptor complex assembly in 
the membrane. 
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Figure 4.4 Models of 
Golgi Trafficking 
A. Progressive/directional 
protein trafficking model 
of Golgi transport. 
Proteins move 
progressively through each 
partition, and exit through 
the trans-Golgi network to 
the membrane. 
 
B. Rapid partitioning in a 
mixed Golgi model. 
Proteins can partition into 
any Golgi compartment, 
and exit directly to the 
plasma membrane, without 
transitioning to the next 
compartment in sequence. 
Images adapted from Glick 
& Luini 2011, Cold Spring 
Harb Perspect Biol. 
Reproduced with 
permission. 
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Figure 4.5 MC4R and B2AR do not undergo complex glycosylation 
Western blot analysis of cells expressing MC4R or B2AR and treated with either Endo H and 
Pngase F. Whole cell lysates of HEK293T cells expressing either receptor where treated with 
Endo H to determine core glycosylated proteins, or Pngase F to cleave all glycans. Proteins were 
analyzed by western blot analysis. 
 
 The Golgi export site of Kir channels is also reported to be the binding site of the AP-1 
adaptor protein. AP-1 adaptor protein binding is required for export of Kir2.3, and Kir4.1/5.1 
channels to the cell surface (Li, Ortega et al. 2016). The authors in this study also suggest that 
Kir7.1 does not share a strong export patch with the other channels and thus may not be needed 
for trafficking, which our preliminary data supports. Given that the SY residues are essential for 
Kir7.1 glycosylation, the AP-1 adaptor proteins or other proteins which bind the site may be 
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essential to facilitate channel glycosylation. Mass spectroscopy analysis experiments of Kir7.1, 
proposed in an earlier section, could reveal adaptor type proteins which bind this site. Whether 
GPCRs block access to these proteins in order to prevent trafficking through the appropriate 
glycosylation pathway could then be tested.  
  
Role for inhibition of Kir7.1 glycosylation in physiology  
 The GPCR mediated inhibition of Kir7.1 glycosylation was discovered while probing the 
original Kir7.1/MC4R interaction. In hypothalamic neurons, Kir7.1 functions to aid MC4R’s role 
in modulating food intake and energy homeostasis (Anderson, Ghamari-Langroudi et al. 2018). 
These data show that activation of MC4R leads to closure of Kir7.1 and inhibition of MC4R by an 
inverse agonist promotes channel opening. These experiments were performed using an 
electrophysiological slice preparation. Erica Anderson a graduate student in the lab took this a step 
further by deleting Kir7.1 within MC4R containing hypothalamic neurons. Within the slice 
preparation, the MC4R agonist failed to cause the neuronal depolarization that was observed when 
Kir7.1 was expressed. Furthermore, these animals had increased weight gain compared to controls 
indicating a role for Kir7.1 in MC4R’s modulation of energy homeostasis. Kir7.1’s  expression is 
quite low within the paraventricular nucleus (PVN) of the hypothalamus where MC4R is 
expressed, and this indicates the sensitivity of the system to the presence of the channel.  
Within the uterine smooth muscle, Kir7.1 activity regulates excitability. Specifically, 
Kir7.1 expression increases in mid-gestation promoting uterine quiescence, and expression levels 
fall significantly prior to labor promoting parturition (McCloskey, Rada et al. 2014). Expressed 
channels also appear to be maintained in an active state, with channel expression inversely 
proportional to uterine excitability. These studies of Kir7.1 in the brain and the uterus represent 
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two different mechanisms by which Kir7.1 activity can be regulated. This research identifies a 
third mechanism, that GPCRs can limit post translational glycosylation of Kir7.1 thereby resulting 
in a channel with reduced activity on the surface of the cell.  
 As described in chapter I, GPCRs that couple through Gq can regulate Kir activity by 
depletion of PIP2. Kir7.1 was recently reported to interact with the oxytocin receptor (OXTR) in 
retinal pigment epithelial cells (York, Halbach et al. 2017). Activation of OXTR led to a reduction 
in Kir7.1 recorded currents from transfected HEK293 cells and also in RPE cells. This was also 
shown to be mediated by PIP2 as expected. In the uterus, oxytocin through OXTR promotes uterine 
contraction, which would also occur around the time of diminished Kir7.1 expression. Indeed, the 
possibility exists that OXT could also function to diminish activity of any remaining Kir7.1 
channels in the smooth muscle. Additionally, given our findings, expression of OXTR could also 
lead to a reduction in the complex glycosylated Kir7.1 channels at the surface. Thus, Kir7.1 could 
be regulated by multiple mechanism based on the signaling within the cell. A proposed model of 
Kir7.1 regulation is shown in figure 4.6. Changes in Kir7.1 complex glycosylation could be 
observed in native tissues supporting this hypothesis. Cornejo et al created an HA-tag knock-in 
mouse for Kir7.1 and observed large variations in glycosylation between tissues, such as trachea 
and lung tissue. Complex glycosylation was observed in the trachea but significantly diminished 
in the lung (Cornejo, Villanueva et al. 2018). B2AR expression is quite high in the alveolar 
epithelium of lung in the smooth muscle lining the airway where it promotes ion transport via PKA 
activation (Mutlu and Factor 2008). Loss of Kir7.1 is not only lethal at birth, but has also been 
linked to retardation of trachea and lung development in mice (Villanueva, Burgos et al. 2015). 
While a role for Kir7.1 in the lung is not clear, it is indeed likely that a GPCR may be responsible 
for the reduction in glycosylation observed. Using this mouse model, complexes of Kir7.1 could 
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be isolated from different tissues to test this hypothesis. 
 In conclusion, regulation of complex glycosylation of Kir7.1 by GPCRs is a new and 
novel mechanism that needs to be further studied. We determined that glycosylation of Kir7.1 is 
essential for function, with Kir1.1 being the only other GPCR for which a role for glycosylation 
in function has be confirmed. Additionally, we have found that MC4R currently remains the only 
GPCR that does not induce changes in Kir7.1 glycosylation, where as other GPCRs tested do. 
However, MC4R is the only GPCR reported to both interact and regulate Kir7.1. This receptor’s 
interaction with Kir7.1 thus appears unique and needs to be explored further. Our research shows 
that multiple mechanism can regulate the function Kir7.1, and indeed identifies a new mechanism 
of interaction between GPCRs and ion channels.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  80 
 
  
 
 
Figure 4.6 Mechanisms of Kir7.1 Regulation 
A. MC4R couples to Kir7.1 to induce channel closure when MC4R is activated by MSH. 
The inverse agonist AGRP promotes channel opening. 
B. Gq coupled receptors such as OXTR activate PLC which converts PIP2 to DAG. PIP2 
depletion leads to channel rundown. 
C. Other GPCRs interact with Kir7.1 possibly in the Golgi, and prevent complex 
glycosylation. Ion channels reaching the surfaced have reduced open channel 
probability.  
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CHAPTER V 
 
METHODS 
 
 
 
Cell lines and cell culture 
HEK293T cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM), with high 
glucose, L-glutamine and phenol red; supplemented with 10% fetal bovine serum (Atlanta 
Biologicals), and 1% antibiotic-antimycotic (Thermo Fisher Scientific). Cultures were 
maintained in 5% CO2 environment at 37°C. Cos1 cells were similarly cultured to HEK293T cell 
lines with medium containing sodium pyruvate. The protein transport inhibitor cocktail from BD 
Biosciences was used at 0.5X and cells were incubated for 9 hours prior to harvesting.  
 
Transfection 
Plasmid DNA constructs were transfected into HEK293T or Cos1 cells at 70-80% confluency 
using LipD293 reagent (SignaGen) according to manufacturer’s instructions. Cells were allowed 
to grow for 24 hours before harvesting. If cells were kept for 48 hours, media was changed after 
24 hours.  
 
Cell surface biotinylation 
Cell surface biotinylation was performed as described in Chandrasekhar et al 
2006(Chandrasekhar, Bas et al. 2006). Briefly, HEK293T cells were transiently co-transfected at 
70-80% confluency with Kir7.1-3XFLAG and either 3HA-β2AR or 3HA-MC4R. 24 hours post 
transfection, cells were washed three times with phosphate buffered saline with calcium and 
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magnesium (PBS2+). Cells were then incubated with 1mg/mL of Biotin-SS-sulfo (ApexBio) in 
PBS2+ twice for 15 minutes each. Excess biotin was quenched with two short washes followed 
by two 15-minute incubations with 100mM glycine in PBS2+. Cells were washed with PBS, then 
lysed with modified RIPA buffer (see western blot protocol). The protein samples were 
quantified, and 25uL of PierceTM high-capacity streptavidin agarose beads (Thermo Scientific) 
were incubated overnight with 75ug of protein lysate. The supernatant was removed and the 
beads were washed three times with lysis buffer. The beads were first eluted with 2x LDS with 
200mM DTT, then with 100mM DTT in lysis buffer. Both elutions were combined, and loaded 
on a 10% BoltTM Bis-Tris Plus gel (Invitrogen) next to 1/5 of the input (15ug of total cell lysate). 
Western blot analysis was continued as described. Samples were quantified as described in the 
next section (Western blot and quantitative analysis). Input lane values post densitometry were 
multiplied by five before comparison to biotinylated lane values. Biotinylated values were taken 
as a percentage of the input lane values to derive the amount of protein at the cell surface. 
Samples with % biotinylated values of less than 1 were excluded from analysis. A minimum of 
four experiments were used for analysis. 
 
Western blots and quantitative analysis 
Post transfection, cells were lysed in a modified RIPA buffer containing 20mM Tris-HCL pH8.0, 
150mM NaCl, 1% Triton X-100, 2mM EDTA and protease inhibitor cocktail (Sigma/Roche). 
Cells were scraped and incubated on ice with rocking for 30 minutes followed by a 10,000 rpm 
centrifugation for 10 minutes. The supernatant was collected and protein quantified using a 
Pierce BCA Protein Assay Kit. Lysates were prepared for denaturing gel electrophoresis by 
mixing with NuPAGE® LDS Sample Buffer (4X) (Invitrogen) with 400mM DTT to a final 
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concentration of 1X LDS, 100mM DTT. Invitrogen BoltTM 10% Bis-Tris Plus precast 
polyacrylamide gels were used to run 10-15 ug of protein at 200V for 40 minutes using BoltTM 
MOPs running buffer. Gels were run with BoltTM running buffer with BoltTM Antioxidant added 
to the first chamber of the mini gel tank (Thermo Fisher Scientific). A Biorad protein ladder, 
Kaleidoscope, Dual Color or All Blue was also included on each gel. The gels were then 
transferred to PVDF membrane (Millipore) using BoltTM Transfer buffer, with the Trans-Blot 
TurboTM Transfer system from Biorad. Membranes were blotted with 5% non-fat dry milk in 
phosphate buffered saline with 1% Tween-20 for 30 minutes, prior to overnight incubation with 
antibodies. Blots were washed a minimum of three times for 10 minutes each before imaging 
with SuperSignalTM West Dura Extended Detection Substrate using the Biorad ChemiDocTM 
Touch Imaging System. Images with samples of interest within the dynamic range were chosen 
for further quantitative analysis using the Biorad Image labTM Software. Ratios of mature to 
immature glycosylation were obtained by dividing the intensity of the upper 50kD doublet, by 
the lower 35kD doublet intensity. No normalization was performed on these values as the ratios 
are independent of protein loading. For comparison of receptor expression levels, intensities 
recorded were normalized to the loading control GAPDH. Data was analyzed using GraphPad 
Prism software. A one or  two-way ANOVA statistical test was used to determine significance 
(p<0.05), with Tukey post-test for multiple comparisons. 
 
Glycosidase treatments 
Membrane proteins traffic through the secretory pathway where post translational modifications 
such as glycans are added before reaching the cell membrane. Channel glycosylation occurs 
initially in the endoplasmic reticulum (ER), before more complex glycans are added in the Golgi. 
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Glycans added in the ER versus the Golgi can be differentiated using endoglycosidases. 
Endoglycosidase H (Endo H) cleaves most immature N-linked glycans which are typically added 
in the ER. Once proteins traffic through the Golgi where more complex glycans are added, the 
protein becomes resistant to Endo H. The enzyme PNGase F however, is able to remove all N-
linked glycans present on the protein, both immature and complex glycosylation. We 
investigated protein glycosylation using the endoglycosidases Endo H and PNGase F from New 
England Biolabs (NEB). Briefly, cells transiently transfected with Kir7.1-3XFLAG or 
Kir7.1ΔSY-3XFLAG were harvested and protein was quantified as previously described. 50ug 
of lysate was denatured by addition of 10x glycoprotein denaturing buffer (NEB) followed by 
heating for 10 minutes at 55ºC. Samples being treated with Endo H were mixed with 
Glycobuffer 3, and 2 ul of Endo H enzyme. The mixture was incubated for 1.5 hours at 37ºC in a 
thermocycler. Samples treated with PNGase F were mixed with GlycoBuffer 2, plus 1 uL of the 
enzyme and also incubated for 1.5 hours at 37ºC. The treated samples were then mixed 
appropriately with 4X NuPAGE LDS buffer with 400mM DTT, and analyzed by western blot 
analysis as described. Samples were compared to untreated lysates and observed for band shifts 
in migration.                                                                                                                                                                
 
Expression constructs 
Plasmids with full length cDNA for the GPCRs β1AR, β2AR, β3AR and MC4R were obtained 
from the cDNA Resource Center (cdna.org), with 3xhemagglutinin (3xHA) N-terminal tags in 
the pcDNA3.1+ expression vector. The full length cDNA sequence for KCNJ13 (AJ006128.1) 
was cloned into the pciNEO expression vector (Promega) with a C terminal 3XFLAG tag 
(Sigma). To create the HA-Kir7.1 construct, the full length cDNA sequence for KCNJ13 was 
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cloned into a pcDNA3.1+ vector with a single N-terminal HA tag.  To create mutations in 
Kir7.1, primers were designed using the NEBaseChanger online tool, and ordered from Sigma. 
Mutagenesis was performed using NEB Q5 Site-Directed Mutagenesis kit (New England 
Biolabs). For electrophysiology, the cDNA sequence of Kir7.1 was cloned into pcDNA5/TO 
expression vector (Thermo Fisher Scientific) without tags. The VSVG-GFP construct was 
provided by the Kenworthy lab at Vanderbilt University. 
 
Antibodies 
Western blotting was performed using the following antibodies: Monoclonal ANTI-FLAG® M2-
Peroxidase (HRP) antibody produced in mouse (Sigma-Aldrich)1:10,000; HA-tag (6E2) Mouse 
mAb (HRP conjugate) (Cell Signaling Technology)1:5000; GAPDH (D16H11)XP® Rabbit 
(HRP conjugate)1:5000, Anti GFP (HRP conjugate) (Abcam) 1:10000.  
 
Structural models and protein alignments 
SWISS-MODEL (Swiss Institute of Bioinformatics) online software was used to generate a 
structural homology model of Kir7.1 based on the published crystal structure of Kir2.2 PDB 
5KUK. Models were visualized using PyMol (Schrodinger). Protein alignments were performed 
with either Clustal Omega (EMBL-EBI) or Lasergene MegAlign software (DNASTAR) using 
the UniProt entry human sequences for Kir7.1(KNCJ13_O60928), Kir4.1 (KCNJ10_P78508), 
Kir5.1 (KCNJ15_Q99712), Kir3.1 (KCNJ3_P48549), Kir2.1 (KCNJ2_P63252), Kir 1.1 
(KCNJ1_P48048). 
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Whole cell electrophysiology 
Whole cell patch-clamp electrophysiology was performed as described in Raphemot et al 
2014(Raphemot, Swale et al. 2014). Briefly, HEK-293T cells were transfected with Kir7.1-
M125R encoding plasmids (0.5μg), MC4R plasmids (3.75 μg) or β2AR plasmids (3.75 μg) and 
EGFP-plasmid (0.05 μg) as a marker for transfections. The following day, cells were dissociated 
with trypsin and plated on poly-l-lysine coated glass coverslips. The plated cells were allowed to 
recover for 1 hour prior to experiments. The cover slips were placed in the recoding chamber on 
an inverted microscope stage and perfused with a bath solution containing 135mM NaCl,  5mM   
KCl,   2mM   CaCl2,   1mM   MgCl2,   5mM   glucose,   10mM   HEPES,   pH   7.4. A Flaming-
Brown P-1000 micropipette puller was used to pull electrodes with resistances between 2 and 3 
MΩ. The pipettes were filled with 135 mM KCl, 2mM MgCl2, 1mM EGTA, 10mM HEPES, pH 
7.3. Transfected cells were identified by EGFP fluorescence, and voltage-clamp conditions were 
used to record whole cell currents. To obtain a current-voltage curve, cells were voltage clamped 
at a holding potential of -75mM, and then stepped to -150mV for 500ms before ramping to 
150mV at a rate of 2.4mv/msec. Cells were superfused with 4mM BaCl2 at the end of the 
experiment to fully block all Kir7.1 channels. This value was used to derive barium inhibitable 
current.  
 
Single channel electrophysiology  
For electrophysiology experiments, cells were plated onto 12 mm cover glass chips at 4 x 104 in 
35 mm diameter culture dishes, transfected after 24 hours with 0.3 μg cDNA of wt Kir 7.1 or Kir 
7.1N95Q, and 0.05 µg of EGFP (to identify transfected cells) using X-tremeGENE9 DNA 
transfection Reagent (Roche Diagnostics, Indianapolis, IN).  Channel activity was recorded 48-72 
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hours after transfection in the cell-attached configuration. Pipettes had resistances of 6-10 MΩ 
when filled with a solution of the following composition (mM): 135 NaCl, 5 KCl, 10 MgCl2, 2 
CaCl2, 5 glucose, 10 HEPES, pH 7.4, with NaOH. Cells were bath-perfused with a high-K+ 
solution of the following composition (mM): 135 KCl, 2 MgCl2, 2 CaCl2, 5 glucose, 10 HEPES, 
pH 7.4, with KOH.  The resting membrane voltage was assumed to be 0 mV. Currents were 
recorded using an Axopatch 200B amplifier, filtered at 2 kHz, sampled at 20 kHz using Digidata 
1550 and saved using pCLAMP 10.4 (Axon Instruments).  Data were analyzed offline using TAC 
4.2 and TACFit 4.2 (Bruxton Corporation) software. Single-channel open and closed events were 
analyzed using the 50% threshold detection method and visually inspected before accepting the 
events.  Single-channel openings occurred as bursts of one or more openings or cluster of bursts.  
Duration time and amplitude histograms were generated using TACFit 4.2 (Bruxton Corporation, 
Seattle, WA, USA).  Single-channel amplitudes (i) were calculated by fitting all-point histograms 
with single- or multi-Gaussian curves.  The difference between the fitted ‘closed’ and ‘open’ peaks 
was taken as i.  Duration histograms were fitted with exponential components in the form: 
∑(ai/τi)exp(–t/τi), where a and τ represent the relative area and time constant of the I component, 
respectively, and t is the time.  Numerical data were expressed as mean ± S.E.M.  Statistical 
analysis was performed using GraphPad Prism version 6.07 for Windows (GraphPad Software, La 
Jolla, CA).  Statistical significance was taken as p < 0.05 using unpaired two-tailed Student's t test. 
 
ER Stress test  
Cells were transiently transfected as previously described with an additional mock transfected 
control. The control cells were treated with BFA/Monesin (0.5x) for 12 hours to induce the 
unfolded protein response. Western blot analysis was performed as previously described, and 
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primary antibodies against CHOP (CST 1:1000), and the spliced isoform of XBP1s (CST 
1:1000), with anti-rabbit secondaries (HRP conjugate 1:10,000) were used to detect ER stress 
markers. Expression of each marker was compared to the BFA/Monesin control and Kir7.1 only 
expressing cells, versus co-expression with GPCRs.  
 
Co-immunoprecipitation  
HEK293T cells were co-transfected with Kir7.1-3xFLAG and 3HA-B2AR and crosslinked with 
1mM DSP dithiobis(succinimidyl propionate (pierce) for 30 minutes. Samples were quenched 
with 20mM Tris HCL for 20 minutes prior to harvesting in lysis buffer. Protein lysate was 
incubated with either anti-Flag M2 antibody (sigma) or anti HA (12CA5) (Vanderbilt antibody 
and protein resource VAPR) overnight with constant rotation at 4C. Protein G magnetic beads 
(Biorad) were added to the overnight lysate antibody sample with further rotation for an 
additional hour. A magnetic rack was used to capture the bead-antibody protein complex, 
followed by three washes with modified RIPA buffer. Protein was eluted from the beads with 2X 
LDS with 200mM DTT buffer, by heating for 10 minutes at 55°C. Eluted samples were analyzed 
by western blot analysis. Un-transfected protein samples, or samples expressing either Kir7.1-
3xFlag or 3xHA-MC4R only were also subject to IP with anti-Flag M2 antibody (sigma) and anti 
HA (12CA5) to rule out non-specific detection of the protein tags. 
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APPENDIX 
 
 
Published as part of Anderson et al 2016 
 “ 60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH” 
 
Anderson, E. J. P., I. Çakir, S. J. Carrington, R. D. Cone, M. Ghamari-Langroudi, T. Gillyard, L. 
E. Gimenez and M. J. Litt (2016) Journal of molecular endocrinology 56(4): T157-T174 
 
 
Kir7.1 and other ion channels 
Based on the finding that AgRP couples MC4R to the pertussis toxin-sensitive Gi/o 
inhibitory protein in the hypothalamic GT1–7 cell line (Buch, Heling et al. 2009), it was 
suggested that MC4R might be coupling to G protein inwardly rectifying potassium 
channels (GIRKs). This result highlights the ability of MC4R to signal through different G 
proteins with opposing actions. One is the canonical (for MC4R) Gsα adenylyl cyclase 
stimulatory action activated by α-MSH vs Gi/o inhibitory protein-dependent pathways 
promoted by AgRP. The ability to signal through Gi/o led to the hypothesis that MC4R 
could potentially couple to GIRKs, known to be activated by Gβγ binding following release 
from Gi heterotrimers (Lei, Jones et al. 2000). Physiologically relevant data on the 
mechanism of α-MSH and AgRP signaling through native MC4R derives from the use of 
electrophysiological slice preparations from mice in which PVH MC4R neurons have been 
transgenically labeled with GFP (Ghamari-Langroudi, Vella et al. 2010, Ghamari-
Langroudi, Srisai et al. 2011). In this preparation, α-MSH depolarizes and AgRP 
hyperpolarizes MC4R neurons when added to the bath. Notably, by using this experimental 
setup in the presence of G protein inhibitors such as GDPβS and gallein, the role of GIRKs 
in α-MSH induced depolarization in MC4R-positive PVH neurons was ruled out. 
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Moreover, Gsα and cAMP signaling were also ruled out, when examined as a potential signaling 
pathway mediating α-MSH-induced depolarization(Ghamari-Langroudi, Digby et al. 2015). 
Current-voltage analyses demonstrated that the conductance involved in α-MSH-induced 
depolarization was a potassium inward rectifier channel (Kir), and a specific subunit, Kir7.1, was 
identified using a panel of specific Kir channel blockers. 
 Also of interest is that AgRP, the endogenous inverse agonist for cAMP responses from 
MC4R, hyperpolarizes PVH neuronsv(Ghamari-Langroudi, Digby et al. 2015). AgRP augmented 
membrane conductance, suggesting increased potassium channel opening and surface density, 
leading to hyperpolarization. Cell transfection studies reinforced the finding that AgRP couples 
the MC4R to Kir7.1 and regulate its opening. The molecular mechanism by which AgRP mediates 
this effect currently remains unknown and will require further studies to be definitively clarified. 
Other inward rectifiers such as Kir2.3 and Kir4.1 channels did not couple to MC4R in independent 
experiments using cultured cells. As Kir channels form homo- and heterotetramers, it remains to 
be determined whether MC4R modulates homotetramers of Kir7.1 or heterotetramers with other 
Kir channel subunits. Kir7.1 modulation by MC4R also presented new pharmacological paradigms 
for the receptor, where some ligands have been found to favor the Gsα vs the Kir7.1 pathway. 
(Ghamari-Langroudi, Digby et al. 2015) reported changes in potency for well-characterized tool 
compounds of MC4R, where the MSH analog MC4-NN2-0453, with an EC50 of 4.9 x 10−9 M for 
intracellular cAMP accumulation assays, was found to have an increased potency of 4.5 x10−9 M 
in a thallium flux-based assay used to measure Kir7.1 coupling. Taken together, these findings 
reveal a novel MC4R signaling pathway, and the potential for the creation of biased ligands that 
favor the ion channel direct interaction/activation paradigm over classical G protein signaling, 
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making this receptor one of only a handful of GPCRs that were shown to couple directly to ion 
channels (Zhang, Li et al. 2014). 
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